ClinicalTrials.gov
History of Changes for Study: NCT02954874
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Latest version (submitted May 18, 2024) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 November 3, 2016 None (earliest Version on record)
2 November 24, 2016 Contacts/Locations and Study Status
3 November 28, 2016 Recruitment Status, Study Status and Contacts/Locations
4 December 15, 2016 Contacts/Locations and Study Status
5 December 19, 2016 Contacts/Locations and Study Status
6 December 20, 2016 Contacts/Locations and Study Status
7 December 28, 2016 Contacts/Locations and Study Status
8 December 30, 2016 Contacts/Locations and Study Status
9 January 2, 2017 Contacts/Locations and Study Status
10 January 5, 2017 Contacts/Locations and Study Status
11 January 9, 2017 Contacts/Locations and Study Status
12 January 11, 2017 Contacts/Locations and Study Status
13 January 12, 2017 Contacts/Locations and Study Status
14 January 13, 2017 Contacts/Locations and Study Status
15 January 16, 2017 Contacts/Locations and Study Status
16 January 18, 2017 Contacts/Locations and Study Status
17 January 19, 2017 Contacts/Locations and Study Status
18 January 20, 2017 Contacts/Locations and Study Status
19 January 23, 2017 Contacts/Locations and Study Status
20 January 24, 2017 Study Status
21 January 30, 2017 Contacts/Locations and Study Status
22 January 31, 2017 Study Status
23 February 3, 2017 Contacts/Locations and Study Status
24 February 6, 2017 Contacts/Locations and Study Status
25 February 7, 2017 Study Status
26 February 8, 2017 Study Status
27 February 9, 2017 Study Status
28 February 13, 2017 Study Status
29 February 14, 2017 Contacts/Locations and Study Status
30 February 15, 2017 Contacts/Locations and Study Status
31 February 16, 2017 Contacts/Locations and Study Status
32 February 20, 2017 Contacts/Locations and Study Status
33 February 21, 2017 Study Status
34 February 23, 2017 Contacts/Locations and Study Status
35 February 27, 2017 Study Status
36 February 28, 2017 Contacts/Locations and Study Status
37 March 1, 2017 Contacts/Locations and Study Status
38 March 2, 2017 Study Status
39 March 3, 2017 Study Status
40 March 6, 2017 Contacts/Locations and Study Status
41 March 8, 2017 Contacts/Locations and Study Status
42 March 9, 2017 Contacts/Locations and Study Status
43 March 10, 2017 Contacts/Locations and Study Status
44 March 13, 2017 Contacts/Locations and Study Status
45 March 17, 2017 Contacts/Locations and Study Status
46 March 21, 2017 Study Status
47 March 22, 2017 Contacts/Locations and Study Status
48 March 27, 2017 Contacts/Locations and Study Status
49 March 30, 2017 Contacts/Locations and Study Status
50 March 31, 2017 Contacts/Locations and Study Status
51 April 3, 2017 Contacts/Locations and Study Status
52 April 4, 2017 Contacts/Locations and Study Status
53 April 6, 2017 Contacts/Locations and Study Status
54 April 7, 2017 Contacts/Locations and Study Status
55 April 11, 2017 Study Status
56 April 12, 2017 Contacts/Locations and Study Status
57 April 13, 2017 Contacts/Locations and Study Status
58 April 14, 2017 Study Status
59 April 17, 2017 Contacts/Locations and Study Status
60 April 19, 2017 Contacts/Locations and Study Status
61 April 20, 2017 Contacts/Locations and Study Status
62 April 21, 2017 Contacts/Locations and Study Status
63 April 24, 2017 Contacts/Locations and Study Status
64 April 25, 2017 Study Status
65 April 26, 2017 Study Status
66 April 27, 2017 Study Status
67 May 1, 2017 Contacts/Locations and Study Status
68 May 3, 2017 Contacts/Locations and Study Status
69 May 5, 2017 Contacts/Locations and Study Status
70 May 10, 2017 Study Status
71 May 11, 2017 Study Status and Contacts/Locations
72 May 12, 2017 Contacts/Locations and Study Status
73 May 16, 2017 Study Status
74 May 17, 2017 Contacts/Locations and Study Status
75 May 19, 2017 Contacts/Locations and Study Status
76 May 23, 2017 Study Status and Contacts/Locations
77 May 24, 2017 Contacts/Locations and Study Status
78 May 26, 2017 Contacts/Locations and Study Status
79 May 29, 2017 Contacts/Locations and Study Status
80 May 31, 2017 Study Status
81 June 2, 2017 Study Status
82 June 13, 2017 Outcome Measures, Study Status, Contacts/Locations, Eligibility and Study Identification
83 June 14, 2017 Study Status
84 June 15, 2017 Contacts/Locations and Study Status
85 June 16, 2017 Contacts/Locations and Study Status
86 June 19, 2017 Contacts/Locations and Study Status
87 June 20, 2017 Contacts/Locations and Study Status
88 June 21, 2017 Study Status
89 June 22, 2017 Contacts/Locations and Study Status
90 June 23, 2017 Contacts/Locations and Study Status
91 June 26, 2017 Arms and Interventions and Study Status
92 June 27, 2017 Study Status
93 June 28, 2017 Contacts/Locations and Study Status
94 June 29, 2017 Contacts/Locations and Study Status
95 June 30, 2017 Study Status
96 July 3, 2017 Contacts/Locations and Study Status
97 July 5, 2017 Contacts/Locations and Study Status
98 July 10, 2017 Contacts/Locations, Arms and Interventions and Study Status
99 July 11, 2017 Study Status
100 July 13, 2017 Contacts/Locations and Study Status
101 July 14, 2017 Contacts/Locations and Study Status
102 July 17, 2017 Contacts/Locations and Study Status
103 July 19, 2017 Study Status
104 July 20, 2017 Study Status
105 July 24, 2017 Study Status
106 July 25, 2017 Study Status
107 July 26, 2017 Study Status
108 July 27, 2017 Contacts/Locations and Study Status
109 July 28, 2017 Contacts/Locations and Study Status
110 July 31, 2017 Contacts/Locations and Study Status
111 August 1, 2017 Contacts/Locations and Study Status
112 August 2, 2017 Contacts/Locations and Study Status
113 August 3, 2017 Contacts/Locations and Study Status
114 August 4, 2017 Contacts/Locations and Study Status
115 August 7, 2017 Study Status
116 August 8, 2017 Study Status
117 August 9, 2017 Study Status
118 August 10, 2017 Contacts/Locations and Study Status
119 August 11, 2017 Contacts/Locations and Study Status
120 August 14, 2017 Contacts/Locations, Arms and Interventions and Study Status
121 August 15, 2017 Study Status
122 August 17, 2017 Study Status
123 August 18, 2017 Contacts/Locations and Study Status
124 August 21, 2017 Contacts/Locations and Study Status
125 August 24, 2017 Contacts/Locations and Study Status
126 August 25, 2017 Contacts/Locations and Study Status
127 August 28, 2017 Contacts/Locations and Study Status
128 August 29, 2017 Study Status
129 August 30, 2017 Contacts/Locations and Study Status
130 September 4, 2017 Arms and Interventions, Contacts/Locations and Study Status
131 September 6, 2017 Study Status
132 September 7, 2017 Study Status
133 September 8, 2017 Study Status
134 September 12, 2017 Study Status
135 September 14, 2017 Contacts/Locations and Study Status
136 September 18, 2017 Contacts/Locations and Study Status
137 September 19, 2017 Study Status
138 September 21, 2017 Contacts/Locations and Study Status
139 September 25, 2017 Contacts/Locations and Study Status
140 September 26, 2017 Contacts/Locations and Study Status
141 September 28, 2017 Contacts/Locations and Study Status
142 October 2, 2017 Contacts/Locations and Study Status
143 October 3, 2017 Contacts/Locations and Study Status
144 October 4, 2017 Contacts/Locations and Study Status
145 October 5, 2017 Contacts/Locations and Study Status
146 October 6, 2017 Contacts/Locations and Study Status
147 October 9, 2017 Contacts/Locations and Study Status
148 October 10, 2017 Study Status
149 October 11, 2017 Contacts/Locations and Study Status
150 October 12, 2017 Study Status
151 October 13, 2017 Contacts/Locations and Study Status
152 October 16, 2017 Conditions and Study Status
153 October 17, 2017 Study Status
154 October 18, 2017 Contacts/Locations and Study Status
155 October 19, 2017 Contacts/Locations and Study Status
156 October 20, 2017 Contacts/Locations and Study Status
157 October 23, 2017 Contacts/Locations and Study Status
158 October 24, 2017 Study Status
159 October 25, 2017 Study Status
160 October 26, 2017 Study Status and Study Identification
161 October 27, 2017 Contacts/Locations and Study Status
162 October 30, 2017 Contacts/Locations and Study Status
163 October 31, 2017 Study Status
164 November 1, 2017 Contacts/Locations and Study Status
165 November 3, 2017 Contacts/Locations and Study Status
166 November 6, 2017 Study Status and Contacts/Locations
167 November 7, 2017 Study Status
168 November 8, 2017 Contacts/Locations and Study Status
169 November 9, 2017 Contacts/Locations and Study Status
170 November 13, 2017 Contacts/Locations and Study Status
171 November 15, 2017 Contacts/Locations and Study Status
172 November 16, 2017 Contacts/Locations and Study Status
173 November 17, 2017 Contacts/Locations and Study Status
174 November 20, 2017 Contacts/Locations and Study Status
175 November 21, 2017 Study Status
176 November 22, 2017 Study Status
177 November 24, 2017 Study Status
178 November 27, 2017 Contacts/Locations and Study Status
179 November 28, 2017 Contacts/Locations and Study Status
180 November 30, 2017 Contacts/Locations and Study Status
181 December 1, 2017 Study Status
182 December 4, 2017 Study Status
183 December 5, 2017 Study Status
184 December 7, 2017 Study Status
185 December 11, 2017 Contacts/Locations, Arms and Interventions and Study Status
186 December 12, 2017 Study Status
187 December 13, 2017 Study Status
188 December 14, 2017 Study Status
189 December 15, 2017 Contacts/Locations and Study Status
190 December 18, 2017 Contacts/Locations and Study Status
191 December 19, 2017 Study Status
192 December 20, 2017 Study Status
193 December 21, 2017 Study Status
194 December 22, 2017 Study Status
195 December 26, 2017 Contacts/Locations and Study Status
196 December 27, 2017 Study Status
197 December 28, 2017 Contacts/Locations and Study Status
198 December 29, 2017 Study Status
199 January 2, 2018 Contacts/Locations and Study Status
200 January 3, 2018 Study Status
201 January 4, 2018 Contacts/Locations and Study Status
202 January 5, 2018 Study Status
203 January 8, 2018 Contacts/Locations and Study Status
204 January 9, 2018 Study Status
205 January 10, 2018 Study Status
206 January 23, 2018 Contacts/Locations, Study Status and Eligibility
207 January 24, 2018 Contacts/Locations and Study Status
208 January 25, 2018 Contacts/Locations and Study Status
209 January 26, 2018 Contacts/Locations and Study Status
210 January 29, 2018 Contacts/Locations and Study Status
211 January 31, 2018 Study Status
212 February 1, 2018 Contacts/Locations and Study Status
213 February 2, 2018 Study Status
214 February 5, 2018 Contacts/Locations and Study Status
215 February 6, 2018 Contacts/Locations and Study Status
216 February 7, 2018 Study Status
217 February 8, 2018 Contacts/Locations and Study Status
218 February 9, 2018 Contacts/Locations and Study Status
219 February 12, 2018 Contacts/Locations and Study Status
220 February 13, 2018 Study Status
221 February 14, 2018 Study Status
222 February 15, 2018 Outcome Measures, Contacts/Locations and Study Status
223 February 16, 2018 Study Status
224 February 19, 2018 Contacts/Locations and Study Status
225 February 20, 2018 Study Status
226 February 22, 2018 Contacts/Locations and Study Status
227 February 23, 2018 Contacts/Locations and Study Status
228 February 26, 2018 Contacts/Locations and Study Status
229 February 27, 2018 Contacts/Locations and Study Status
230 February 28, 2018 Contacts/Locations and Study Status
231 March 1, 2018 Contacts/Locations and Study Status
232 March 2, 2018 Study Status
233 March 5, 2018 Contacts/Locations and Study Status
234 March 7, 2018 Contacts/Locations and Study Status
235 March 8, 2018 Contacts/Locations and Study Status
236 March 9, 2018 Contacts/Locations and Study Status
237 March 12, 2018 Contacts/Locations and Study Status
238 March 13, 2018 Study Status
239 March 14, 2018 Contacts/Locations and Study Status
240 March 15, 2018 Study Status
241 March 16, 2018 Contacts/Locations and Study Status
242 March 19, 2018 Contacts/Locations and Study Status
243 March 20, 2018 Contacts/Locations and Study Status
244 March 21, 2018 Contacts/Locations and Study Status
245 March 22, 2018 Contacts/Locations and Study Status
246 March 26, 2018 Contacts/Locations and Study Status
247 March 29, 2018 Contacts/Locations and Study Status
248 April 2, 2018 Contacts/Locations and Study Status
249 April 3, 2018 Contacts/Locations and Study Status
250 April 4, 2018 Contacts/Locations and Study Status
251 April 9, 2018 Contacts/Locations and Study Status
252 April 12, 2018 Contacts/Locations and Study Status
253 April 16, 2018 Contacts/Locations and Study Status
254 April 17, 2018 Contacts/Locations and Study Status
255 April 18, 2018 Contacts/Locations and Study Status
256 April 20, 2018 Contacts/Locations and Study Status
257 April 23, 2018 Contacts/Locations and Study Status
258 April 25, 2018 Contacts/Locations and Study Status
259 April 26, 2018 Contacts/Locations and Study Status
260 April 27, 2018 Contacts/Locations and Study Status
261 April 30, 2018 Contacts/Locations and Study Status
262 May 2, 2018 Contacts/Locations and Study Status
263 May 3, 2018 Contacts/Locations and Study Status
264 May 7, 2018 Contacts/Locations and Study Status
265 May 11, 2018 Contacts/Locations and Study Status
266 May 14, 2018 Contacts/Locations and Study Status
267 May 16, 2018 Contacts/Locations and Study Status
268 May 18, 2018 Contacts/Locations and Study Status
269 May 21, 2018 Contacts/Locations and Study Status
270 May 22, 2018 Contacts/Locations and Study Status
271 May 23, 2018 Contacts/Locations and Study Status
272 May 24, 2018 Contacts/Locations and Study Status
273 June 11, 2018 Contacts/Locations, Arms and Interventions, Study Description and Study Status
274 June 14, 2018 Contacts/Locations and Study Status
275 June 18, 2018 Contacts/Locations and Study Status
276 June 21, 2018 Contacts/Locations and Study Status
277 June 22, 2018 Study Status
278 June 25, 2018 Contacts/Locations and Study Status
279 June 27, 2018 Contacts/Locations and Study Status
280 June 28, 2018 Contacts/Locations and Study Status
281 June 29, 2018 Contacts/Locations and Study Status
282 July 2, 2018 Contacts/Locations and Study Status
283 July 6, 2018 Contacts/Locations and Study Status
284 July 9, 2018 Contacts/Locations and Study Status
285 July 11, 2018 Contacts/Locations and Study Status
286 July 13, 2018 Contacts/Locations and Study Status
287 July 16, 2018 Contacts/Locations and Study Status
288 July 18, 2018 Contacts/Locations and Study Status
289 July 19, 2018 Contacts/Locations and Study Status
290 July 20, 2018 Contacts/Locations and Study Status
291 July 23, 2018 Contacts/Locations and Study Status
292 July 24, 2018 Contacts/Locations and Study Status
293 July 25, 2018 Contacts/Locations and Study Status
294 July 26, 2018 Contacts/Locations and Study Status
295 July 27, 2018 Contacts/Locations and Study Status
296 July 30, 2018 Contacts/Locations and Study Status
297 July 31, 2018 Contacts/Locations and Study Status
298 August 1, 2018 Contacts/Locations and Study Status
299 August 2, 2018 Contacts/Locations and Study Status
300 August 3, 2018 Contacts/Locations and Study Status
301 August 6, 2018 Contacts/Locations and Study Status
302 August 8, 2018 Contacts/Locations and Study Status
303 August 9, 2018 Contacts/Locations and Study Status
304 August 10, 2018 Contacts/Locations and Study Status
305 August 14, 2018 Contacts/Locations and Study Status
306 August 15, 2018 Contacts/Locations and Study Status
307 August 16, 2018 Contacts/Locations and Study Status
308 August 17, 2018 Contacts/Locations and Study Status
309 August 20, 2018 Contacts/Locations and Study Status
310 August 21, 2018 Contacts/Locations and Study Status
311 August 23, 2018 Contacts/Locations and Study Status
312 August 24, 2018 Contacts/Locations and Study Status
313 August 27, 2018 Contacts/Locations and Study Status
314 August 30, 2018 Contacts/Locations and Study Status
315 August 31, 2018 Contacts/Locations and Study Status
316 September 6, 2018 Contacts/Locations and Study Status
317 September 7, 2018 Contacts/Locations and Study Status
318 September 10, 2018 Contacts/Locations and Study Status
319 September 11, 2018 Contacts/Locations and Study Status
320 September 12, 2018 Contacts/Locations and Study Status
321 September 13, 2018 Contacts/Locations and Study Status
322 September 14, 2018 Contacts/Locations and Study Status
323 September 17, 2018 Contacts/Locations and Study Status
324 September 18, 2018 Contacts/Locations and Study Status
325 September 19, 2018 Contacts/Locations and Study Status
326 September 20, 2018 Contacts/Locations and Study Status
327 September 21, 2018 Contacts/Locations and Study Status
328 September 24, 2018 Contacts/Locations and Study Status
329 September 25, 2018 Contacts/Locations and Study Status
330 September 26, 2018 Contacts/Locations and Study Status
331 September 27, 2018 Contacts/Locations and Study Status
332 September 28, 2018 Contacts/Locations and Study Status
333 October 1, 2018 Contacts/Locations and Study Status
334 October 3, 2018 Contacts/Locations and Study Status
335 October 4, 2018 Contacts/Locations and Study Status
336 October 5, 2018 Contacts/Locations and Study Status
337 October 8, 2018 Contacts/Locations and Study Status
338 October 9, 2018 Contacts/Locations and Study Status
339 October 10, 2018 Contacts/Locations and Study Status
340 October 11, 2018 Contacts/Locations and Study Status
341 October 12, 2018 Contacts/Locations and Study Status
342 October 15, 2018 Contacts/Locations and Study Status
343 October 17, 2018 Contacts/Locations and Study Status
344 October 18, 2018 Contacts/Locations and Study Status
345 October 19, 2018 Contacts/Locations and Study Status
346 October 22, 2018 Contacts/Locations and Study Status
347 October 23, 2018 Contacts/Locations and Study Status
348 October 24, 2018 Contacts/Locations and Study Status
349 October 25, 2018 Contacts/Locations and Study Status
350 October 26, 2018 Contacts/Locations and Study Status
351 October 30, 2018 Contacts/Locations and Study Status
352 October 31, 2018 Contacts/Locations and Study Status
353 November 1, 2018 Contacts/Locations and Study Status
354 November 2, 2018 Contacts/Locations and Study Status
355 November 5, 2018 Contacts/Locations and Study Status
356 November 6, 2018 Contacts/Locations and Study Status
357 November 7, 2018 Contacts/Locations and Study Status
358 November 8, 2018 Contacts/Locations and Study Status
359 November 9, 2018 Contacts/Locations and Study Status
360 November 13, 2018 Contacts/Locations and Study Status
361 November 14, 2018 Contacts/Locations and Study Status
362 November 15, 2018 Contacts/Locations and Study Status
363 November 16, 2018 Contacts/Locations and Study Status
364 November 19, 2018 Contacts/Locations and Study Status
365 November 20, 2018 Contacts/Locations and Study Status
366 November 23, 2018 Contacts/Locations and Study Status
367 December 4, 2018 Contacts/Locations and Study Status
368 December 5, 2018 Contacts/Locations and Study Status
369 December 6, 2018 Contacts/Locations and Study Status
370 December 7, 2018 Contacts/Locations and Study Status
371 December 10, 2018 Contacts/Locations and Study Status
372 December 13, 2018 Contacts/Locations and Study Status
373 December 14, 2018 Contacts/Locations and Study Status
374 December 17, 2018 Contacts/Locations and Study Status
375 December 18, 2018 Contacts/Locations and Study Status
376 December 19, 2018 Contacts/Locations and Study Status
377 December 20, 2018 Contacts/Locations and Study Status
378 December 21, 2018 Contacts/Locations and Study Status
379 December 24, 2018 Contacts/Locations and Study Status
380 December 27, 2018 Contacts/Locations and Study Status
381 December 31, 2018 Contacts/Locations and Study Status
382 January 7, 2019 Contacts/Locations and Study Status
383 January 8, 2019 Contacts/Locations and Study Status
384 January 11, 2019 Contacts/Locations and Study Status
385 January 14, 2019 Contacts/Locations and Study Status
386 January 16, 2019 Contacts/Locations and Study Status
387 January 17, 2019 Contacts/Locations and Study Status
388 January 18, 2019 Contacts/Locations and Study Status
389 January 22, 2019 Contacts/Locations and Study Status
390 January 23, 2019 Contacts/Locations and Study Status
391 January 24, 2019 Contacts/Locations and Study Status
392 January 25, 2019 Contacts/Locations and Study Status
393 January 28, 2019 Contacts/Locations and Study Status
394 January 29, 2019 Contacts/Locations and Study Status
395 January 30, 2019 Contacts/Locations and Study Status
396 January 31, 2019 Contacts/Locations and Study Status
397 February 1, 2019 Contacts/Locations and Study Status
398 February 4, 2019 Contacts/Locations and Study Status
399 February 14, 2019 Contacts/Locations and Study Status
400 February 15, 2019 Contacts/Locations and Study Status
401 February 19, 2019 Contacts/Locations and Study Status
402 February 20, 2019 Contacts/Locations and Study Status
403 February 21, 2019 Contacts/Locations and Study Status
404 February 22, 2019 Contacts/Locations and Study Status
405 February 25, 2019 Contacts/Locations and Study Status
406 February 27, 2019 Contacts/Locations and Study Status
407 February 28, 2019 Contacts/Locations and Study Status
408 March 1, 2019 Contacts/Locations and Study Status
409 March 4, 2019 Contacts/Locations and Study Status
410 March 5, 2019 Contacts/Locations and Study Status
411 March 6, 2019 Contacts/Locations and Study Status
412 March 7, 2019 Contacts/Locations and Study Status
413 March 11, 2019 Contacts/Locations and Study Status
414 March 12, 2019 Contacts/Locations and Study Status
415 March 13, 2019 Contacts/Locations and Study Status
416 March 14, 2019 Contacts/Locations and Study Status
417 March 15, 2019 Contacts/Locations and Study Status
418 March 18, 2019 Contacts/Locations and Study Status
419 March 19, 2019 Contacts/Locations and Study Status
420 March 20, 2019 Contacts/Locations and Study Status
421 March 21, 2019 Contacts/Locations and Study Status
422 March 22, 2019 Contacts/Locations and Study Status
423 March 25, 2019 Contacts/Locations and Study Status
424 March 28, 2019 Contacts/Locations and Study Status
425 April 1, 2019 Contacts/Locations and Study Status
426 April 2, 2019 Contacts/Locations and Study Status
427 April 4, 2019 Contacts/Locations and Study Status
428 April 5, 2019 Contacts/Locations and Study Status
429 April 8, 2019 Contacts/Locations and Study Status
430 April 9, 2019 Contacts/Locations and Study Status
431 April 10, 2019 Contacts/Locations and Study Status
432 April 12, 2019 Contacts/Locations and Study Status
433 April 15, 2019 Contacts/Locations and Study Status
434 April 16, 2019 Contacts/Locations and Study Status
435 April 22, 2019 Contacts/Locations and Study Status
436 April 24, 2019 Contacts/Locations and Study Status
437 April 26, 2019 Contacts/Locations and Study Status
438 April 29, 2019 Contacts/Locations and Study Status
439 April 30, 2019 Contacts/Locations and Study Status
440 May 6, 2019 Contacts/Locations and Study Status
441 May 9, 2019 Contacts/Locations and Study Status
442 May 10, 2019 Contacts/Locations and Study Status
443 May 13, 2019 Contacts/Locations and Study Status
444 May 14, 2019 Contacts/Locations and Study Status
445 May 15, 2019 Contacts/Locations and Study Status
446 May 16, 2019 Contacts/Locations and Study Status
447 May 20, 2019 Contacts/Locations and Study Status
448 May 21, 2019 Contacts/Locations and Study Status
449 May 22, 2019 Contacts/Locations and Study Status
450 May 23, 2019 Contacts/Locations and Study Status
451 May 24, 2019 Contacts/Locations and Study Status
452 May 27, 2019 Contacts/Locations and Study Status
453 May 29, 2019 Contacts/Locations and Study Status
454 May 30, 2019 Contacts/Locations and Study Status
455 June 3, 2019 Contacts/Locations, Arms and Interventions and Study Status
456 June 5, 2019 Contacts/Locations and Study Status
457 June 6, 2019 Contacts/Locations and Study Status
458 June 7, 2019 Contacts/Locations and Study Status
459 June 10, 2019 Contacts/Locations, Arms and Interventions and Study Status
460 June 11, 2019 Contacts/Locations and Study Status
461 June 12, 2019 Contacts/Locations and Study Status
462 June 13, 2019 Contacts/Locations and Study Status
463 June 14, 2019 Contacts/Locations and Study Status
464 June 19, 2019 Contacts/Locations and Study Status
465 June 20, 2019 Contacts/Locations and Study Status
466 June 21, 2019 Contacts/Locations and Study Status
467 June 24, 2019 Contacts/Locations and Study Status
468 June 26, 2019 Contacts/Locations and Study Status
469 June 27, 2019 Contacts/Locations and Study Status
470 July 1, 2019 Contacts/Locations and Study Status
471 July 2, 2019 Contacts/Locations and Study Status
472 July 3, 2019 Contacts/Locations and Study Status
473 July 5, 2019 Contacts/Locations and Study Status
474 July 8, 2019 Contacts/Locations and Study Status
475 July 11, 2019 Contacts/Locations and Study Status
476 July 12, 2019 Contacts/Locations and Study Status
477 July 15, 2019 Contacts/Locations and Study Status
478 July 16, 2019 Contacts/Locations and Study Status
479 July 18, 2019 Contacts/Locations and Study Status
480 July 22, 2019 Contacts/Locations and Study Status
481 July 24, 2019 Contacts/Locations and Study Status
482 July 25, 2019 Contacts/Locations and Study Status
483 July 26, 2019 Contacts/Locations and Study Status
484 July 29, 2019 Contacts/Locations and Study Status
485 July 31, 2019 Contacts/Locations and Study Status
486 August 1, 2019 Contacts/Locations and Study Status
487 August 2, 2019 Contacts/Locations and Study Status
488 August 5, 2019 Contacts/Locations and Study Status
489 August 6, 2019 Contacts/Locations and Study Status
490 August 7, 2019 Contacts/Locations and Study Status
491 August 8, 2019 Contacts/Locations and Study Status
492 August 12, 2019 Contacts/Locations and Study Status
493 August 13, 2019 Contacts/Locations and Study Status
494 August 14, 2019 Contacts/Locations and Study Status
495 August 26, 2019 Outcome Measures, Contacts/Locations, Study Description, Eligibility, Arms and Interventions, Oversight, Study Status and Study Identification
496 August 27, 2019 Contacts/Locations and Study Status
497 August 29, 2019 Contacts/Locations and Study Status
498 August 30, 2019 Contacts/Locations and Study Status
499 September 2, 2019 Contacts/Locations and Study Status
500 September 4, 2019 Contacts/Locations and Study Status
501 September 5, 2019 Contacts/Locations and Study Status
502 September 6, 2019 Contacts/Locations and Study Status
503 September 9, 2019 Contacts/Locations and Study Status
504 September 11, 2019 Contacts/Locations and Study Status
505 September 12, 2019 Contacts/Locations and Study Status
506 September 16, 2019 Contacts/Locations and Study Status
507 September 18, 2019 Contacts/Locations and Study Status
508 September 19, 2019 Contacts/Locations and Study Status
509 September 20, 2019 Contacts/Locations and Study Status
510 September 23, 2019 Contacts/Locations and Study Status
511 September 24, 2019 Contacts/Locations and Study Status
512 September 25, 2019 Contacts/Locations and Study Status
513 September 26, 2019 Contacts/Locations and Study Status
514 September 27, 2019 Contacts/Locations and Study Status
515 September 30, 2019 Contacts/Locations and Study Status
516 October 2, 2019 Contacts/Locations and Study Status
517 October 3, 2019 Contacts/Locations and Study Status
518 October 4, 2019 Conditions and Study Status
519 October 7, 2019 Contacts/Locations and Study Status
520 October 9, 2019 Contacts/Locations and Study Status
521 October 10, 2019 Contacts/Locations and Study Status
522 October 11, 2019 Arms and Interventions and Study Status
523 October 14, 2019 Arms and Interventions and Study Status
524 October 15, 2019 Contacts/Locations and Study Status
525 October 17, 2019 Contacts/Locations and Study Status
526 October 21, 2019 Contacts/Locations and Study Status
527 October 23, 2019 Contacts/Locations and Study Status
528 October 24, 2019 Contacts/Locations and Study Status
529 October 25, 2019 Contacts/Locations and Study Status
530 October 28, 2019 Contacts/Locations and Study Status
531 October 30, 2019 Contacts/Locations and Study Status
532 October 31, 2019 Contacts/Locations and Study Status
533 November 1, 2019 Contacts/Locations and Study Status
534 November 4, 2019 Contacts/Locations and Study Status
535 November 5, 2019 Contacts/Locations and Study Status
536 November 6, 2019 Contacts/Locations and Study Status
537 November 7, 2019 Contacts/Locations and Study Status
538 November 12, 2019 Contacts/Locations and Study Status
539 November 14, 2019 Contacts/Locations and Study Status
540 November 15, 2019 Contacts/Locations and Study Status
541 November 18, 2019 Contacts/Locations, Arms and Interventions and Study Status
542 November 19, 2019 Contacts/Locations and Study Status
543 November 20, 2019 Contacts/Locations and Study Status
544 November 21, 2019 Contacts/Locations and Study Status
545 November 22, 2019 Contacts/Locations and Study Status
546 November 25, 2019 Contacts/Locations and Study Status
547 November 29, 2019 Contacts/Locations and Study Status
548 December 2, 2019 Contacts/Locations and Study Status
549 December 3, 2019 Contacts/Locations and Study Status
550 December 4, 2019 Contacts/Locations and Study Status
551 December 5, 2019 Contacts/Locations and Study Status
552 December 6, 2019 Contacts/Locations and Study Status
553 December 9, 2019 Contacts/Locations, Arms and Interventions and Study Status
554 December 12, 2019 Contacts/Locations and Study Status
555 December 13, 2019 Contacts/Locations and Study Status
556 December 16, 2019 Contacts/Locations and Study Status
557 December 17, 2019 Contacts/Locations and Study Status
558 December 18, 2019 Contacts/Locations and Study Status
559 December 19, 2019 Contacts/Locations and Study Status
560 December 20, 2019 Contacts/Locations and Study Status
561 December 23, 2019 Contacts/Locations and Study Status
562 December 25, 2019 Contacts/Locations and Study Status
563 December 27, 2019 Contacts/Locations and Study Status
564 December 30, 2019 Contacts/Locations and Study Status
565 December 31, 2019 Contacts/Locations and Study Status
566 January 2, 2020 Contacts/Locations and Study Status
567 January 3, 2020 Contacts/Locations and Study Status
568 January 6, 2020 Contacts/Locations and Study Status
569 January 7, 2020 Contacts/Locations and Study Status
570 January 8, 2020 Contacts/Locations and Study Status
571 January 10, 2020 Contacts/Locations and Study Status
572 January 13, 2020 Contacts/Locations and Study Status
573 January 14, 2020 Contacts/Locations and Study Status
574 January 15, 2020 Contacts/Locations and Study Status
575 January 16, 2020 Contacts/Locations and Study Status
576 January 17, 2020 Contacts/Locations and Study Status
577 January 20, 2020 Contacts/Locations, Arms and Interventions and Study Status
578 January 22, 2020 Contacts/Locations and Study Status
579 January 23, 2020 Contacts/Locations and Study Status
580 January 24, 2020 Contacts/Locations and Study Status
581 January 27, 2020 Contacts/Locations and Study Status
582 January 28, 2020 Contacts/Locations and Study Status
583 January 29, 2020 Contacts/Locations and Study Status
584 January 30, 2020 Contacts/Locations and Study Status
585 January 31, 2020 Contacts/Locations and Study Status
586 February 3, 2020 Contacts/Locations, Arms and Interventions and Study Status
587 February 5, 2020 Contacts/Locations and Study Status
588 February 6, 2020 Contacts/Locations and Study Status
589 February 7, 2020 Contacts/Locations and Study Status
590 February 10, 2020 Contacts/Locations and Study Status
591 February 11, 2020 Contacts/Locations and Study Status
592 February 12, 2020 Contacts/Locations and Study Status
593 February 25, 2020 Contacts/Locations, Eligibility, Study Description, Oversight, Study Status and Study Identification
594 February 26, 2020 Contacts/Locations and Study Status
595 February 27, 2020 Contacts/Locations and Study Status
596 February 28, 2020 Contacts/Locations and Study Status
597 March 2, 2020 Contacts/Locations, Arms and Interventions and Study Status
598 March 4, 2020 Contacts/Locations and Study Status
599 March 5, 2020 Contacts/Locations and Study Status
600 March 6, 2020 Contacts/Locations and Study Status
601 March 9, 2020 Contacts/Locations and Study Status
602 March 11, 2020 Contacts/Locations and Study Status
603 March 12, 2020 Contacts/Locations and Study Status
604 March 13, 2020 Contacts/Locations and Study Status
605 March 16, 2020 Contacts/Locations and Study Status
606 March 18, 2020 Contacts/Locations and Study Status
607 March 20, 2020 Contacts/Locations and Study Status
608 March 23, 2020 Contacts/Locations and Study Status
609 March 24, 2020 Contacts/Locations and Study Status
610 April 1, 2020 Contacts/Locations, Eligibility, Outcome Measures, Study Description, Study Status and Study Identification
611 April 2, 2020 Contacts/Locations and Study Status
612 April 3, 2020 Contacts/Locations and Study Status
613 April 7, 2020 Contacts/Locations and Study Status
614 April 9, 2020 Contacts/Locations and Study Status
615 April 11, 2020 Contacts/Locations and Study Status
616 April 14, 2020 Contacts/Locations, Arms and Interventions and Study Status
617 April 15, 2020 Contacts/Locations and Study Status
618 April 16, 2020 Contacts/Locations and Study Status
619 April 17, 2020 Contacts/Locations and Study Status
620 April 18, 2020 Contacts/Locations and Study Status
621 April 21, 2020 Contacts/Locations and Study Status
622 April 23, 2020 Contacts/Locations and Study Status
623 April 24, 2020 Contacts/Locations and Study Status
624 April 25, 2020 Study Status
625 April 28, 2020 Contacts/Locations and Study Status
626 April 29, 2020 Contacts/Locations and Study Status
627 April 30, 2020 Contacts/Locations and Study Status
628 May 2, 2020 Contacts/Locations, Arms and Interventions and Study Status
629 May 5, 2020 Contacts/Locations and Study Status
630 May 6, 2020 Contacts/Locations and Study Status
631 May 7, 2020 Contacts/Locations and Study Status
632 May 8, 2020 Contacts/Locations and Study Status
633 May 9, 2020 Contacts/Locations and Study Status
634 May 12, 2020 Contacts/Locations and Study Status
635 May 13, 2020 Contacts/Locations and Study Status
636 May 14, 2020 Contacts/Locations and Study Status
637 May 16, 2020 Contacts/Locations and Study Status
638 May 19, 2020 Contacts/Locations and Study Status
639 May 21, 2020 Contacts/Locations and Study Status
640 May 22, 2020 Contacts/Locations and Study Status
641 May 26, 2020 Contacts/Locations and Study Status
642 May 27, 2020 Contacts/Locations and Study Status
643 May 28, 2020 Contacts/Locations and Study Status
644 May 29, 2020 Contacts/Locations and Study Status
645 May 30, 2020 Contacts/Locations and Study Status
646 June 3, 2020 Contacts/Locations and Study Status
647 June 4, 2020 Contacts/Locations and Study Status
648 June 6, 2020 Contacts/Locations and Study Status
649 June 11, 2020 Contacts/Locations and Study Status
650 June 13, 2020 Contacts/Locations and Study Status
651 June 16, 2020 Contacts/Locations and Study Status
652 June 17, 2020 Contacts/Locations and Study Status
653 June 19, 2020 Contacts/Locations and Study Status
654 June 20, 2020 Contacts/Locations and Study Status
655 June 23, 2020 Contacts/Locations and Study Status
656 June 24, 2020 Contacts/Locations and Study Status
657 June 25, 2020 Contacts/Locations and Study Status
658 June 26, 2020 Contacts/Locations and Study Status
659 June 27, 2020 Contacts/Locations and Study Status
660 June 30, 2020 Contacts/Locations and Study Status
661 July 1, 2020 Contacts/Locations and Study Status
662 July 2, 2020 Contacts/Locations and Study Status
663 July 4, 2020 Contacts/Locations and Study Status
664 July 7, 2020 Contacts/Locations and Study Status
665 July 8, 2020 Contacts/Locations and Study Status
666 July 9, 2020 Contacts/Locations and Study Status
667 July 10, 2020 Contacts/Locations and Study Status
668 July 14, 2020 Contacts/Locations and Study Status
669 July 15, 2020 Contacts/Locations and Study Status
670 July 16, 2020 Contacts/Locations and Study Status
671 July 17, 2020 Contacts/Locations and Study Status
672 July 18, 2020 Contacts/Locations and Study Status
673 July 21, 2020 Contacts/Locations and Study Status
674 July 22, 2020 Contacts/Locations and Study Status
675 July 23, 2020 Contacts/Locations and Study Status
676 July 24, 2020 Contacts/Locations and Study Status
677 July 25, 2020 Contacts/Locations and Study Status
678 July 28, 2020 Contacts/Locations and Study Status
679 July 29, 2020 Contacts/Locations and Study Status
680 July 30, 2020 Contacts/Locations and Study Status
681 August 1, 2020 Contacts/Locations and Study Status
682 August 4, 2020 Contacts/Locations and Study Status
683 August 5, 2020 Contacts/Locations and Study Status
684 August 6, 2020 Contacts/Locations and Study Status
685 August 7, 2020 Contacts/Locations and Study Status
686 August 8, 2020 Contacts/Locations and Study Status
687 August 11, 2020 Contacts/Locations and Study Status
688 August 13, 2020 Contacts/Locations and Study Status
689 August 19, 2020 Contacts/Locations and Study Status
690 August 21, 2020 Contacts/Locations and Study Status
691 August 22, 2020 Contacts/Locations and Study Status
692 August 25, 2020 Contacts/Locations and Study Status
693 August 27, 2020 Contacts/Locations and Study Status
694 August 28, 2020 Contacts/Locations and Study Status
695 August 29, 2020 Contacts/Locations and Study Status
696 September 1, 2020 Contacts/Locations and Study Status
697 September 2, 2020 Contacts/Locations and Study Status
698 September 3, 2020 Contacts/Locations and Study Status
699 September 4, 2020 Contacts/Locations and Study Status
700 September 8, 2020 Contacts/Locations and Study Status
701 September 9, 2020 Contacts/Locations and Study Status
702 September 10, 2020 Contacts/Locations and Study Status
703 September 11, 2020 Contacts/Locations and Study Status
704 September 12, 2020 Contacts/Locations and Study Status
705 September 15, 2020 Contacts/Locations and Study Status
706 September 16, 2020 Contacts/Locations and Study Status
707 September 17, 2020 Contacts/Locations and Study Status
708 September 18, 2020 Contacts/Locations and Study Status
709 September 19, 2020 Contacts/Locations and Study Status
710 September 24, 2020 Contacts/Locations and Study Status
711 September 25, 2020 Contacts/Locations and Study Status
712 September 29, 2020 Contacts/Locations and Study Status
713 October 1, 2020 Contacts/Locations and Study Status
714 October 2, 2020 Contacts/Locations and Study Status
715 October 3, 2020 Contacts/Locations and Study Status
716 October 6, 2020 Contacts/Locations and Study Status
717 October 7, 2020 Contacts/Locations and Study Status
718 October 8, 2020 Contacts/Locations and Study Status
719 October 9, 2020 Contacts/Locations and Study Status
720 October 10, 2020 Contacts/Locations and Study Status
721 October 13, 2020 Contacts/Locations and Study Status
722 October 14, 2020 Contacts/Locations and Study Status
723 October 15, 2020 Contacts/Locations and Study Status
724 October 16, 2020 Contacts/Locations and Study Status
725 October 17, 2020 Contacts/Locations and Study Status
726 October 20, 2020 Contacts/Locations and Study Status
727 October 21, 2020 Contacts/Locations and Study Status
728 October 22, 2020 Contacts/Locations and Study Status
729 October 23, 2020 Contacts/Locations and Study Status
730 October 24, 2020 Contacts/Locations and Study Status
731 October 27, 2020 Contacts/Locations and Study Status
732 October 28, 2020 Contacts/Locations and Study Status
733 October 29, 2020 Contacts/Locations and Study Status
734 November 4, 2020 Contacts/Locations, Arms and Interventions and Study Status
735 November 6, 2020 Contacts/Locations and Study Status
736 November 7, 2020 Contacts/Locations and Study Status
737 November 10, 2020 Contacts/Locations and Study Status
738 November 12, 2020 Contacts/Locations and Study Status
739 November 13, 2020 Contacts/Locations and Study Status
740 November 14, 2020 Contacts/Locations and Study Status
741 November 17, 2020 Contacts/Locations and Study Status
742 November 18, 2020 Contacts/Locations and Study Status
743 November 19, 2020 Contacts/Locations and Study Status
744 November 21, 2020 Contacts/Locations and Study Status
745 November 24, 2020 Contacts/Locations and Study Status
746 November 25, 2020 Contacts/Locations and Study Status
747 December 1, 2020 Contacts/Locations and Study Status
748 December 12, 2020 Contacts/Locations and Study Status
749 December 15, 2020 Arms and Interventions and Study Status
750 December 19, 2020 Contacts/Locations and Study Status
751 December 22, 2020 Contacts/Locations and Study Status
752 December 23, 2020 Contacts/Locations and Study Status
753 December 24, 2020 Contacts/Locations and Study Status
754 December 29, 2020 Contacts/Locations and Study Status
755 December 30, 2020 Contacts/Locations and Study Status
756 December 31, 2020 Contacts/Locations and Study Status
757 January 1, 2021 Contacts/Locations and Study Status
758 January 5, 2021 Contacts/Locations and Study Status
759 January 6, 2021 Contacts/Locations and Study Status
760 January 7, 2021 Contacts/Locations and Study Status
761 January 8, 2021 Contacts/Locations and Study Status
762 January 9, 2021 Contacts/Locations and Study Status
763 January 12, 2021 Contacts/Locations and Study Status
764 January 13, 2021 Contacts/Locations and Study Status
765 January 14, 2021 Contacts/Locations and Study Status
766 January 15, 2021 Contacts/Locations and Study Status
767 January 19, 2021 Contacts/Locations and Study Status
768 January 20, 2021 Contacts/Locations and Study Status
769 January 22, 2021 Study Status
770 January 23, 2021 Contacts/Locations and Study Status
771 February 5, 2021 Recruitment Status, Study Status, Contacts/Locations, Eligibility, Study Design and Study Identification
772 February 6, 2021 Study Status
773 February 9, 2021 Recruitment Status, Study Status and Contacts/Locations
774 February 10, 2021 Contacts/Locations and Study Status
775 February 11, 2021 Contacts/Locations and Study Status
776 February 12, 2021 Contacts/Locations and Study Status
777 February 13, 2021 Contacts/Locations and Study Status
778 February 16, 2021 Contacts/Locations and Study Status
779 February 17, 2021 Contacts/Locations and Study Status
780 February 18, 2021 Contacts/Locations and Study Status
781 February 19, 2021 Contacts/Locations and Study Status
782 February 20, 2021 Contacts/Locations and Study Status
783 February 23, 2021 Contacts/Locations and Study Status
784 February 24, 2021 Contacts/Locations and Study Status
785 February 25, 2021 Contacts/Locations and Study Status
786 February 26, 2021 Contacts/Locations and Study Status
787 February 27, 2021 Contacts/Locations, Study Design and Study Status
788 March 2, 2021 Contacts/Locations and Study Status
789 March 3, 2021 Contacts/Locations and Study Status
790 March 4, 2021 Contacts/Locations and Study Status
791 March 5, 2021 Contacts/Locations and Study Status
792 March 6, 2021 Contacts/Locations and Study Status
793 March 11, 2021 Contacts/Locations and Study Status
794 March 13, 2021 Contacts/Locations and Study Status
795 March 16, 2021 Contacts/Locations and Study Status
796 March 17, 2021 Contacts/Locations and Study Status
797 March 18, 2021 Contacts/Locations and Study Status
798 March 19, 2021 Contacts/Locations and Study Status
799 March 20, 2021 Contacts/Locations and Study Status
800 March 23, 2021 Contacts/Locations and Study Status
801 March 24, 2021 Contacts/Locations and Study Status
802 March 25, 2021 Contacts/Locations and Study Status
803 March 27, 2021 Contacts/Locations and Study Status
804 March 31, 2021 Contacts/Locations and Study Status
805 April 1, 2021 Contacts/Locations and Study Status
806 April 2, 2021 Contacts/Locations and Study Status
807 April 3, 2021 Contacts/Locations and Study Status
808 April 6, 2021 Contacts/Locations and Study Status
809 April 9, 2021 Contacts/Locations and Study Status
810 April 13, 2021 Contacts/Locations and Study Status
811 April 14, 2021 Contacts/Locations and Study Status
812 April 15, 2021 Contacts/Locations and Study Status
813 April 17, 2021 Contacts/Locations and Study Status
814 April 20, 2021 Contacts/Locations and Study Status
815 April 21, 2021 Contacts/Locations and Study Status
816 April 22, 2021 Contacts/Locations and Study Status
817 April 23, 2021 Contacts/Locations and Study Status
818 April 24, 2021 Contacts/Locations and Study Status
819 April 28, 2021 Contacts/Locations and Study Status
820 April 30, 2021 Contacts/Locations and Study Status
821 May 1, 2021 Contacts/Locations and Study Status
822 May 4, 2021 Contacts/Locations and Study Status
823 May 5, 2021 Contacts/Locations and Study Status
824 May 6, 2021 Contacts/Locations and Study Status
825 May 7, 2021 Contacts/Locations and Study Status
826 May 11, 2021 Contacts/Locations and Study Status
827 May 12, 2021 Contacts/Locations and Study Status
828 May 13, 2021 Contacts/Locations and Study Status
829 May 14, 2021 Contacts/Locations and Study Status
830 May 15, 2021 Contacts/Locations and Study Status
831 May 18, 2021 Contacts/Locations and Study Status
832 May 20, 2021 Contacts/Locations and Study Status
833 May 22, 2021 Contacts/Locations and Study Status
834 May 25, 2021 Contacts/Locations and Study Status
835 May 27, 2021 Contacts/Locations and Study Status
836 May 28, 2021 Contacts/Locations and Study Status
837 June 1, 2021 Contacts/Locations and Study Status
838 June 2, 2021 Contacts/Locations and Study Status
839 June 3, 2021 Contacts/Locations and Study Status
840 June 4, 2021 Contacts/Locations and Study Status
841 June 8, 2021 Contacts/Locations and Study Status
842 June 9, 2021 Contacts/Locations and Study Status
843 June 10, 2021 Contacts/Locations and Study Status
844 June 11, 2021 Contacts/Locations and Study Status
845 June 12, 2021 Contacts/Locations and Study Status
846 June 16, 2021 Contacts/Locations and Study Status
847 June 17, 2021 Contacts/Locations and Study Status
848 June 18, 2021 Contacts/Locations and Study Status
849 June 22, 2021 Contacts/Locations and Study Status
850 June 24, 2021 Contacts/Locations and Study Status
851 June 25, 2021 Contacts/Locations and Study Status
852 June 26, 2021 Contacts/Locations and Study Status
853 June 29, 2021 Contacts/Locations and Study Status
854 June 30, 2021 Contacts/Locations and Study Status
855 July 1, 2021 Recruitment Status, Study Status and Contacts/Locations
856 July 2, 2021 Study Status
857 July 30, 2021 Study Status
858 August 3, 2021 Study Status
859 August 18, 2021 Contacts/Locations and Study Status
860 August 26, 2021 Contacts/Locations and Study Status
861 September 25, 2021 Contacts/Locations and Study Status
862 October 8, 2021 Contacts/Locations and Study Status
863 November 30, 2021 Oversight and Study Status
864 December 8, 2021 Study Status
865 December 22, 2021 Contacts/Locations and Study Status
866 February 26, 2022 Contacts/Locations and Study Status
867 April 5, 2022 Study Status
868 April 28, 2022 Contacts/Locations and Study Status
869 April 29, 2022 Contacts/Locations and Study Status
870 May 27, 2022 Contacts/Locations and Study Status
871 June 7, 2022 Arms and Interventions and Study Status
872 June 10, 2022 Contacts/Locations and Study Status
873 June 18, 2022 Contacts/Locations and Study Status
874 June 25, 2022 Contacts/Locations and Study Status
875 June 29, 2022 Study Status and Arms and Interventions
876 July 20, 2022 Contacts/Locations and Study Status
877 August 5, 2022 Contacts/Locations and Study Status
878 August 30, 2022 Contacts/Locations and Study Status
879 September 23, 2022 Contacts/Locations and Study Status
880 October 18, 2022 Contacts/Locations and Study Status
881 December 30, 2022 Contacts/Locations and Study Status
882 January 27, 2023 Study Status
883 January 28, 2023 Contacts/Locations and Study Status
884 February 10, 2023 Contacts/Locations and Study Status
885 March 7, 2023 Arms and Interventions and Study Status
886 March 29, 2023 Contacts/Locations and Study Status
887 April 19, 2023 Arms and Interventions, Eligibility, Conditions, Study Description and Study Status
888 April 27, 2023 Study Status
889 May 2, 2023 Contacts/Locations, Arms and Interventions and Study Status
890 May 13, 2023 Study Status
891 June 16, 2023 Contacts/Locations and Study Status
892 July 14, 2023 Contacts/Locations and Study Status
893 July 28, 2023 Contacts/Locations and Study Status
894 August 8, 2023 Arms and Interventions and Study Status
895 September 9, 2023 Contacts/Locations and Study Status
896 September 20, 2023 Contacts/Locations and Study Status
897 September 29, 2023 Study Status and Oversight
898 December 2, 2023 Study Status
899 January 6, 2024 Contacts/Locations and Study Status
900 January 9, 2024 Contacts/Locations and Study Status
901 February 14, 2024 Contacts/Locations and Study Status
902 April 3, 2024 Contacts/Locations and Study Status
903 May 7, 2024 Arms and Interventions and Study Status
904 May 15, 2024 Contacts/Locations and Study Status
905 May 16, 2024 Contacts/Locations and Study Status
906 May 18, 2024 Contacts/Locations and Study Status
Comparison Format:
Scroll up to access the controls
Study NCT02954874
Submitted Date:  October 2, 2017 (v142)
Open or close this module Study Identification
Unique Protocol ID: NCI-2016-01595
Brief Title: Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Official Title: A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With ≥ 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Secondary IDs: NCI-2016-01595 [Registry Identifier: CTRP (Clinical Trial Reporting Program)]
S1418/BR006
S1418 [SWOG]
S1418 [CTEP]
U10CA180888 [U.S. NIH Grant/Contract]
Open or close this module Study Status
Record Verification: June 2017
Overall Status: Recruiting
Study Start: November 15, 2016
Primary Completion: May 31, 2026 [Anticipated]
Study Completion: May 31, 2026 [Anticipated]
First Submitted: November 3, 2016
First Submitted that
Met QC Criteria:		 November 3, 2016
First Posted: November 4, 2016 [Estimate]
Last Update Submitted that
Met QC Criteria:		 October 2, 2017
Last Update Posted: October 3, 2017 [Actual]
Open or close this module Sponsor/Collaborators
Sponsor: National Cancer Institute (NCI)
Responsible Party: Sponsor
Collaborators:
Open or close this module Oversight
U.S. FDA-regulated Drug:
U.S. FDA-regulated Device:
Data Monitoring: No
Open or close this module Study Description
Brief Summary: This randomized phase III trial studies how well pembrolizumab works in treating triple-negative breast cancer. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Detailed Description:

PRIMARY OBJECTIVES:

I. To compare invasive disease-free survival (IDFS) of patients with triple-negative breast cancer (TNBC) who have either >= 1 cm residual invasive breast cancer and/or positive lymph nodes (> ypN+) after neoadjuvant chemotherapy randomized to receive 1 year of MK-3475 (pembrolizumab) adjuvant therapy compared to no MK-3475 (pembrolizumab), in both the entire study population and also in the PD-L1 positive subset.

SECONDARY OBJECTIVES:

I. To compare the effects of MK-3475 (pembrolizumab) on overall survival (OS) and distant recurrence-free survival (DRFS) between the two randomized arms for the PD-L1 positive patients and then all patients.

II. To assess the toxicity and tolerability of MK-3475 (pembrolizumab) in this patient population with or without radiation therapy.

TERTIARY OBJECTIVES:

I. To examine the association between biomarkers of inflammation and quality of life and patient reported outcomes between the two groups during and at the end of therapy.

II. To examine the long-term and late effects of treatment on patient-reported outcomes.

III. To collect tissue and whole blood for processing and banking in anticipation of future correlative studies in this patient population.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (OBSERVATION): Patients receive no treatment but are monitored at standard clinical intervals during first year after randomization. Patients are examined every 12 weeks for 1 year, and every 6 months for 4 years, then annually for 5 years.

ARM II (PEMROLIZUMAB): Patients receive pembrolizumab intravenously (IV) over 30 minutes on days 1 and 22. Courses repeat every 42 days for 52 weeks in the absence of disease progression or unacceptable toxicity.

All patients may undergo radiation therapy within 12 weeks of last breast cancer operation or after treatment.

After completion of study treatment, patients are followed up to 10 years.
Open or close this module Conditions
Conditions: Estrogen Receptor Negative
HER2/Neu Negative
Invasive Breast Carcinoma
Progesterone Receptor Negative
Stage 0 Breast Cancer
Stage I Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage III Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Triple-Negative Breast Carcinoma
Keywords:
Open or close this module Study Design
Study Type: Interventional
Primary Purpose: Treatment
Study Phase: Phase 3
Interventional Study Model: Parallel Assignment
Number of Arms: 2
Masking: None (Open Label)
Allocation: Randomized
Enrollment: 1000 [Anticipated]
Open or close this module Arms and Interventions
Arms Assigned Interventions
Experimental: Arm I (observation)
Patients receive no treatment but are monitored at standard clinical intervals during first year after randomization. Patients are examined every 12 weeks for 1 year, every 6 months for 4 years, and then annually for 5 years. Patients may undergo radiation therapy within 12 weeks of last breast cancer operation or after treatment.
Laboratory Biomarker Analysis
Correlative studies
Patient Observation
Undergo standard monitoring
Other Names:
  • active surveillance
  • deferred therapy
  • expectant management
  • Observation
  • Watchful Waiting
Quality-of-Life Assessment
Ancillary studies
Other Names:
  • Quality of Life Assessment
Questionnaire Administration
Ancillary studies
Radiation: Radiation Therapy
Undergo radiation therapy
Other Names:
  • Cancer Radiotherapy
  • Irradiate
  • Irradiated
  • irradiation
  • Radiation
  • Radiotherapeutics
  • Radiotherapy
  • RT
  • Therapy, Radiation
Experimental: Arm II (pembrolizumab)
Patients receive pembrolizumab IV over 30 minutes on days 1 and 22. Courses repeat every 42 days for 52 weeks in the absence of disease progression or unacceptable toxicity. Patients may undergo radiation therapy within 12 weeks of last breast cancer operation or after treatment.
Laboratory Biomarker Analysis
Correlative studies
Biological: Pembrolizumab
Given IV
Other Names:
  • Keytruda
  • Lambrolizumab
  • MK-3475
  • SCH 900475
Quality-of-Life Assessment
Ancillary studies
Other Names:
  • Quality of Life Assessment
Questionnaire Administration
Ancillary studies
Radiation: Radiation Therapy
Undergo radiation therapy
Other Names:
  • Cancer Radiotherapy
  • Irradiate
  • Irradiated
  • irradiation
  • Radiation
  • Radiotherapeutics
  • Radiotherapy
  • RT
  • Therapy, Radiation
Open or close this module Outcome Measures
Primary Outcome Measures:
1. Invasive disease-free survival (IDFS)
[ Time Frame: From date of randomization to date of first invasive recurrence, second invasive primary cancer (breast or not), or death due to any cause, assessed up to 10 years ]

The distributions of IDFS will be estimated using the Kaplan-Meier method, with 95% confidence intervals (CI) calculated using Greenwood's formula. Comparisons between the two treatment arms will be performed using the stratified log-rank test. The hazard ratios and 95% CIs will be based on the stratified Cox proportional hazard model with treatment as the only covariate. Secondary analyses of IDFS will be performed to describe consistency or divergence across subgroups. This will include a forest plot of treatment hazard ratios and associated 95% confidence intervals for each level of the str
2. Physical function reported by patients measured by Patient Reported Outcomes Measurement Information System (PROMIS) Global physical health scale
[ Time Frame: 55 weeks after randomization ]

Will be compared between the two treatment groups by means of multiple linear regression with adjustment for the corresponding baseline measurement as well as whether or not the patient received radiation therapy which is known to be associated with post-treatment fatigue. No multiple comparisons adjustment will be employed since these outcomes evaluate the toxicity of the investigational drug. The clinical meaningfulness of each comparison will be considered.
3. Severity of fatigue measured by Patient Reported Outcomes Measurement Information System (PROMIS) fatigue scale
[ Time Frame: 55 weeks after randomization ]

Will be compared between the two treatment groups by means of multiple linear regression with adjustment for the corresponding baseline measurement as well as whether or not the patient received radiation therapy which is known to be associated with post-treatment fatigue. No multiple comparisons adjustment will be employed since these outcomes evaluate the toxicity of the investigational drug. The clinical meaningfulness of each comparison will be considered.
Secondary Outcome Measures:
1. Distant recurrence-free survival (DRFS)
[ Time Frame: From date of randomization to date of invasive distant disease recurrence, second invasive primary cancer (breast or not) or death due to any cause, assessed up to 10 years ]

The distributions of DRFS will be estimated using the Kaplan-Meier method, with 95% CI calculated using Greenwood's formula. Comparisons between the two treatment arms will be performed using the stratified log-rank test. The hazard ratios and 95% CIs will be based on the stratified Cox proportional hazard model with treatment as the only covariate.
2. Emotional function and disease-related symptoms in patients receiving pembrolizumab assessed by Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale score
[ Time Frame: Up to 10 years ]

Will be compared between the two treatment groups using a mixed model for repeated measures analysis with adjustment for the baseline score and time. Presence of treatment-by-time interaction will be investigated.
3. Impact of treatment and treatment-related symptoms on physical function in patients without therapy
[ Time Frame: 55 weeks after randomization ]

Compared to patients receiving pembrolizumab. A multiple linear regression model will be performed with physical health scale score as an outcome and treatment and treatment related symptoms as covariates. Presence of treatment by each individual symptom item interactions will be investigated.
4. Incidence of adverse events assessed by National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0
[ Time Frame: Up to 10 years ]

Toxicity analysis will be conducted in all patients receiving at least one dose of MK-3475 (pembrolizumab). The incidence of adverse events will be reported.
5. Long-term quality of life and symptoms between the two treatment groups
[ Time Frame: Up to 60 months after randomization ]

Mixed models for repeated measures analysis will be used with adjustment for scores at 18 months to examine changes in physical and emotional domain scores, fatigue and other persistent symptoms over the course
6. Overall survival (OS)
[ Time Frame: From date of randomization to date of death due to any cause, assessed up to 10 years ]

The distributions of OS will be estimated using the Kaplan-Meier method, with 95% CI calculated using Greenwood's formula. Comparisons between the two treatment arms will be performed using the stratified log-rank test. The hazard ratios and 95% CIs will be based on the stratified Cox proportional hazard model with treatment as the only covariate.
7. Relationship between treatment-related symptoms and adherence to the study medication
[ Time Frame: Up to 10 years ]

Will be investigated among patients randomized to pembrolizumab treatment group by means of multiple logistic regression. Patients who have been on study therapy for 70% or more of their expected time on therapy will be considered adherent.
8. Resolution of treatment-related symptoms in patients receiving pembrolizumab
[ Time Frame: 18 months after randomization ]

Compared to patients without treatment. A change in severity of the particular symptom will be compared between the two treatment groups by means of multiple linear regression with adjustment for the corresponding measurement at the 55 week assessment point.
9. Role of pro-inflammatory cytokines in the development of pembrolizumab associated symptoms
[ Time Frame: Up to 55 weeks ]

Specifically focused on treatment-associated fatigue. This will be compared to patients in the observation group.
10. Severity and frequency of treatment-related symptoms (diarrhea, nausea, rash, cough, and shortness of breath, musculoskeletal pain) over time of patients receiving pembrolizumab
[ Time Frame: Up to 10 years ]

Compared without treatment. The distributions of the corresponding Patient Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) items will be compared between the two treatment groups using a mixed ordinal logistic regression model for repeated measures. The model will also include the corresponding baseline measurement and time. Presence of treatment-by-time interaction will be tested for each of these endpoints. Similar analyses will be performed for disease related symptoms. The descriptive and graphical methods suggested in Basch, et. al. will be used to
11. Single nucleotide polymorphisms (SNPs) in the promotor region of pro-inflammatory cytokine genes and the risk for development and severity of treatment-associated fatigue and other symptoms
[ Time Frame: Up to 10 years ]

The role of these SNPs in the persistence of long-term fatigue in all patients will also be explored using treatment assignment as a covariate.
Open or close this module Eligibility
Minimum Age: 18 Years
Maximum Age:
Sex: All
Gender Based:
Accepts Healthy Volunteers: No
Criteria:

Inclusion Criteria:

  • STEP 1 REGISTRATION
  • Patients must have histologically confirmed estrogen receptor (ER)-, progesterone receptor (PR)- and HER2-negative (triple-negative, TNBC) with residual invasive breast cancer, as defined by the 2010 and 2013 American Society of Clinical Oncology (ASCO) College of American Pathologists (CAP) guidelines, after completion of neoadjuvant chemotherapy; residual disease must be >= 1 cm in greatest dimension, and/or have positive lymph nodes (ypN+) observed on pathologic exam
    • NOTE: Immunohistochemistry (IHC)-positive isolated tumor cells in the lymph node (N0 [i+]) are not considered node-positive and these patients also must have >= 1 cm residual invasive cancer in the breast in order to be eligible
  • Patients must not have metastatic disease (i.e., must be M0)
  • It is preferred that axillary lymph node sampling is performed after completion of neoadjuvant chemotherapy to allow more accurate assessment of pathologic response; patients must have a complete axillary lymph node dissection after neoadjuvant chemotherapy in the following situations (exceptions will be granted for patients participating in the Alliance A11202 trial):
    • Patients had documented pathologic involvement of the axillary nodes (fine needle aspiration [FNA] or core biopsy) before neoadjuvant chemotherapy and had sentinel node biopsy after neoadjuvant chemotherapy with positive sentinel node(s)
    • Patient had documented pathologic involvement of the axillary nodes (FNA or core biopsy) before neoadjuvant chemotherapy and had only 1 sentinel lymph node removed after neoadjuvant chemotherapy
      • NOTE: Patients who undergo sentinel node biopsy before starting neoadjuvant treatment and do not undergo post neoadjuvant assessment of the axillary nodes or who have negative axillary nodes on post neoadjuvant assessment must have >= 1 cm residual invasive cancer in the breast after completion of neoadjuvant chemotherapy
  • Patients must have a minimum of five, available unstained slides from the residual (post-neoadjuvant) invasive tumor in primary site or lymph node to be submitted within 7 days after registration to determine PD-L1 expression; the tumor tissue must be adequate for PD-L1 testing, which typically requires a minimum of 100 cancer cells per slide
  • Patients must be offered the opportunity to participate in specimen banking
  • Patients must have had neoadjuvant chemotherapy followed by surgery; the recommended neoadjuvant treatment should include 16-24 weeks of a third generation chemotherapy regimen as recommended by National Comprehensive Cancer Network (NCCN) guidelines for triple negative breast cancer (examples include dose dense adriamycin-cytoxan [AC] followed by dose-dense paclitaxel; weekly paclitaxel x 12 followed or preceded by cyclophosphamide-adriamycin-fluorouracil [FAC], fluorouracil-epirubicin-cytoxan [FEC], AC or dose dense AC; docetaxel either followed or preceded by FEC/FAC or AC; carboplatin-containing neoadjuvant chemotherapy is also allowed); patients who cannot complete all planned treatment cycles for any reason are considered high risk and therefore are eligible for the study if they have residual disease; patients must have resolution of adverse event(s) of the most recent prior chemotherapy to grade 1 or less, except alopecia and =< grade 2 neuropathy which are allowed
  • Patients may receive post-operative (adjuvant) chemotherapy for up to 24 weeks of duration (e.g. 8 cycles of capecitabine as in the CREATE-X trial) after completion of surgery at the discretion of the treating physician; patients must have resolution of adverse event(s) of the most recent prior chemotherapy to grade 1 or less, except alopecia and =< grade 2 neuropathy which are allowed; adjuvant chemotherapy, if administered, must have been completed within 35 days prior to screening registration and must be given prior to radiation
  • Patients must have completed their final breast surgery (rendering them free from disease) with clear resection margins for invasive cancer and ductal carcinoma in situ (DCIS) within 90 days prior to screening registration for patients not receiving post-operative (adjuvant) chemotherapy, or within 210 days prior to screening registration for patients who have completed post-operative (adjuvant) chemotherapy; positive margins are allowed only if the surgical team of the patient deems further resection impossible
  • Patients for whom radiation therapy (RT) to the affected breast or chest wall and regional nodal areas is clinically indicated as per NCCN treatment guidelines, should receive RT after randomization when possible, concomitant with MK-3475 (pembrolizumab) if randomized to the experimental arm; however, RT administered prior to registration is also allowed; patients must specify at the time of screening registration whether or not they will receive RT and the extent of intended RT
  • Patients must not have had prior immunotherapy with anti-PD-L1, anti-PD-1, anti-CTLA4 or similar drugs; patients must not be planning to receive any of the prohibited therapies during the screening or treatment phases of the study
  • Patients must not be planning to receive concomitantly other biologic therapy, hormonal therapy, other chemotherapy, surgery or other anti-cancer therapy except radiation therapy while receiving treatment on this protocol
  • Patients must have Zubrod performance status =< 2
  • Patients must not have a history of (non-infectious) pneumonitis that required steroids or evidence of active pneumonitis
  • Patients must not have an active infection requiring systemic therapy
  • Patients must not have active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs); replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment
  • Patients must not have received live vaccines within 30 days prior to registration; examples of live vaccines include, but are not limited to, the following: measles, mumps, rubella, chicken pox, shingles, yellow fever, rabies, Bacillus Calmette-Guerin (BCG), and typhoid (oral) vaccine; seasonal influenza vaccines for injection are generally killed virus vaccines and are allowed; however, intranasal influenza vaccines (e.g., Flu-Mist) are live attenuated vaccines, and are not allowed
  • Patients must not have known active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection prior to registration; patients who have completed curative therapy for HCV are eligible; patients with known human immunodeficiency virus (HIV) infection are eligible if they meet each of the following 3 criteria:
    • CD4 counts >= 350 mm^3
    • Serum HIV viral load of < 25,000 IU/ml and
    • Treated on a stable antiretroviral regimen
  • No other prior invasive malignancy is allowed except for the following: adequately treated basal (or squamous cell) skin cancer, in situ breast or cervical cancer; stage I or II invasive cancer treated with a curative intent without evidence of disease recurrence for at least five years
  • Patients must be informed of the investigational nature of this study and must sign and give written informed consent for this protocol in accordance with institutional and federal guidelines
  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
  • STEP 2 REGISTRATION
  • Patients must not be registered to step 2 until receiving confirmation from the Southwest Oncology Group (SWOG) Statistical Center that the patient's tissue specimen was adequate for PD-L1 testing; patients must be registered within 7 days of receiving the e-mail notification confirming submission was evaluable for PD-L1 status
  • A serum thyroid-stimulating hormone (TSH) must be obtained within 28 days prior to step 2 registration to obtain a baseline value
  • Absolute neutrophil count (ANC) >= 1,500 microliter (mcL)
  • Platelets >= 100,000/mcL
  • Hemoglobin >= 9 g/dL
  • Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except Gilbert's syndrome, who must have a total bilirubin < 3.0 mg/dL)
  • Serum glutamic-oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 2.5 x IULN
  • Alkaline phosphatase =< 2.5 x IULN
  • Serum creatinine =< IULN OR measured or calculated creatinine clearance >= 60 mL/min
  • Women of childbearing potential must have a negative urine or serum pregnancy test within 28 day prior to registration; women/men of reproductive potential must have agreed to use an effective contraceptive method for the course of the study through 120 days after the last dose of study medication; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately; a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy, bilateral tubal ligation, or vasectomy; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures; patients must not be pregnant or nursing
  • Site must verify that there is no known change in the step 1 eligibility since initial registration
Open or close this module Contacts/Locations
Study Officials: Lajos Pusztai
Principal Investigator
SWOG Cancer Research Network
Locations: United States, Alaska
Alaska Oncology and Hematology LLC
[Recruiting]
Anchorage, Alaska, United States, 99508
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Anchorage Oncology Centre
[Recruiting]
Anchorage, Alaska, United States, 99508
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Katmai Oncology Group
[Recruiting]
Anchorage, Alaska, United States, 99508
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Providence Alaska Medical Center
[Recruiting]
Anchorage, Alaska, United States, 99508
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Fairbanks Memorial Hospital
[Recruiting]
Fairbanks, Alaska, United States, 99701
Contact:Contact: John A. Keech 907-458-5380
Contact:Principal Investigator: John A. Keech
United States, Arizona
University of Arizona Cancer Center-North Campus
[Recruiting]
Tucson, Arizona, United States, 85719
Contact:Contact: Simran K. Sindhu 520-626-9008
Contact:Principal Investigator: Simran K. Sindhu
The University of Arizona Medical Center-University Campus
[Recruiting]
Tucson, Arizona, United States, 85724
Contact:Contact: Simran K. Sindhu 520-626-9008
Contact:Principal Investigator: Simran K. Sindhu
United States, Arkansas
Highlands Oncology Group-Rogers
[Suspended]
Rogers, Arkansas, United States, 72758
United States, California
Kaiser Permanente-Anaheim
[Recruiting]
Anaheim, California, United States, 92807
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Sutter Auburn Faith Hospital
[Recruiting]
Auburn, California, United States, 95602
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
AIS Cancer Center at San Joaquin Community Hospital
[Recruiting]
Bakersfield, California, United States, 93301
Contact:Contact: Helen K. Chew 916-734-3089
Contact:Principal Investigator: Helen K. Chew
Kaiser Permanente-Baldwin Park
[Recruiting]
Baldwin Park, California, United States, 91706
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Kaiser Permanente-Bellflower
[Recruiting]
Bellflower, California, United States, 90706
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Alta Bates Summit Medical Center-Herrick Campus
[Recruiting]
Berkeley, California, United States, 94704
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Mills-Peninsula Medical Center
[Recruiting]
Burlingame, California, United States, 94010
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
City of Hope Comprehensive Cancer Center
[Recruiting]
Duarte, California, United States, 91010
Contact:Contact: Joanne E. Mortimer 800-826-4673 becomingapatient@coh.org
Contact:Principal Investigator: Joanne E. Mortimer
Epic Care-Dublin
[Recruiting]
Dublin, California, United States, 94568
Contact:Contact: James H. Feusner protocols@swog.org
Contact:Principal Investigator: James H. Feusner
Bay Area Breast Surgeons Inc
[Recruiting]
Emeryville, California, United States, 94608
Contact:Contact: James H. Feusner protocols@swog.org
Contact:Principal Investigator: James H. Feusner
Epic Care Partners in Cancer Care
[Recruiting]
Emeryville, California, United States, 94608
Contact:Contact: James H. Feusner protocols@swog.org
Contact:Principal Investigator: James H. Feusner
Kaiser Permanente Hospital
[Recruiting]
Fontana, California, United States, 92335
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Kaiser Permanente - Harbor City
[Recruiting]
Harbor City, California, United States, 90710
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Kaiser Permanente-Irvine
[Recruiting]
Irvine, California, United States, 92618
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Kaiser Permanente Los Angeles Medical Center
[Recruiting]
Los Angeles, California, United States, 90027
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Los Angeles County-USC Medical Center
[Recruiting]
Los Angeles, California, United States, 90033
Contact:Contact: Min J. Lu 323-865-0451
Contact:Principal Investigator: Min J. Lu
USC / Norris Comprehensive Cancer Center
[Recruiting]
Los Angeles, California, United States, 90033
Contact:Contact: Min J. Lu 323-865-0451
Contact:Principal Investigator: Min J. Lu
Kaiser Permanente-Cadillac
[Recruiting]
Los Angeles, California, United States, 90034
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Contra Costa Regional Medical Center
[Recruiting]
Martinez, California, United States, 94553-3156
Contact:Contact: James H. Feusner protocols@swog.org
Contact:Principal Investigator: James H. Feusner
Fremont - Rideout Cancer Center
[Recruiting]
Marysville, California, United States, 95901
Contact:Contact: Helen K. Chew 916-734-3089
Contact:Principal Investigator: Helen K. Chew
Memorial Medical Center
[Recruiting]
Modesto, California, United States, 95355
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Camino Division
[Recruiting]
Mountain View, California, United States, 94040
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Gynecologic Oncology
[Recruiting]
Mountain View, California, United States, 94040
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
USC Norris Oncology/Hematology-Newport Beach
[Recruiting]
Newport Beach, California, United States, 92663
Contact:Contact: Min J. Lu 323-865-0451
Contact:Principal Investigator: Min J. Lu
Sutter Cancer Research Consortium
[Recruiting]
Novato, California, United States, 94945
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Alta Bates Summit Medical Center - Summit Campus
[Recruiting]
Oakland, California, United States, 94609
Contact:Contact: James H. Feusner protocols@swog.org
Contact:Principal Investigator: James H. Feusner
Bay Area Tumor Institute
[Recruiting]
Oakland, California, United States, 94609
Contact:Contact: James H. Feusner protocols@swog.org
Contact:Principal Investigator: James H. Feusner
Kaiser Permanente-Ontario
[Recruiting]
Ontario, California, United States, 91761
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Saint Joseph Hospital - Orange
[Recruiting]
Orange, California, United States, 92868
Contact:Contact: Timothy E. Byun 714-734-6220
Contact:Principal Investigator: Timothy E. Byun
UC Irvine Health/Chao Family Comprehensive Cancer Center
[Recruiting]
Orange, California, United States, 92868
Contact:Contact: Chaitali S. Nangia 877-827-8839 ucstudy@uci.edu
Contact:Principal Investigator: Chaitali S. Nangia
Palo Alto Medical Foundation Health Care
[Recruiting]
Palo Alto, California, United States, 94301
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Stanford Cancer Institute Palo Alto
[Recruiting]
Palo Alto, California, United States, 94304
Contact:Contact: Melinda L. Telli 650-498-7061 ccto-office@stanford.edu
Contact:Principal Investigator: Melinda L. Telli
Kaiser Permanente - Panorama City
[Recruiting]
Panorama City, California, United States, 91402
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Kaiser Permanente-Riverside
[Recruiting]
Riverside, California, United States, 92505
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Sutter Roseville Medical Center
[Recruiting]
Roseville, California, United States, 95661
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Sutter Medical Center Sacramento
[Recruiting]
Sacramento, California, United States, 95816
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
University of California Davis Comprehensive Cancer Center
[Recruiting]
Sacramento, California, United States, 95817
Contact:Contact: Helen K. Chew 916-734-3089
Contact:Principal Investigator: Helen K. Chew
Kaiser Permanente-San Diego Mission
[Recruiting]
San Diego, California, United States, 92108
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Kaiser Permanente-San Diego Zion
[Recruiting]
San Diego, California, United States, 92120
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
California Pacific Medical Center-Pacific Campus
[Recruiting]
San Francisco, California, United States, 94115
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Pacific Central Coast Health Center-San Luis Obispo
[Recruiting]
San Luis Obispo, California, United States, 93401
Contact:Contact: Brian A. DiCarlo Diane.DeVos-Schmidt@DignityHealth.org
Contact:Principal Investigator: Brian A. DiCarlo
Kaiser Permanente-San Marcos
[Recruiting]
San Marcos, California, United States, 92069
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
Palo Alto Medical Foundation-Santa Cruz
[Recruiting]
Santa Cruz, California, United States, 95065
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Palo Alto Medical Foundation-Sunnyvale
[Recruiting]
Sunnyvale, California, United States, 94086
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Gene Upshaw Memorial Tahoe Forest Cancer Center
[Recruiting]
Truckee, California, United States, 96161
Contact:Contact: Helen K. Chew 916-734-3089
Contact:Principal Investigator: Helen K. Chew
Sutter Solano Medical Center/Cancer Center
[Recruiting]
Vallejo, California, United States, 94589
Contact:Contact: Ari D. Baron 415-209-2686 bernicl@sutterhealth.org
Contact:Principal Investigator: Ari D. Baron
Kaiser Permanente
[Recruiting]
Woodland Hills, California, United States, 91367
Contact:Contact: Jonathan A. Polikoff 626-564-3455
Contact:Principal Investigator: Jonathan A. Polikoff
United States, Colorado
University of Colorado Hospital
[Recruiting]
Aurora, Colorado, United States, 80045
Contact:Contact: Anthony D. Elias 970-297-6150
Contact:Principal Investigator: Anthony D. Elias
Rocky Mountain Cancer Centers-Boulder
[Recruiting]
Boulder, Colorado, United States, 80304
Contact:Contact: Keren Sturtz 303-777-2663 ccrp@co-cancerresearch.org
Contact:Principal Investigator: Keren Sturtz
Penrose-Saint Francis Healthcare
[Recruiting]
Colorado Springs, Colorado, United States, 80907
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Memorial Hospital Central
[Recruiting]
Colorado Springs, Colorado, United States, 80909
Contact:Contact: Anthony D. Elias 970-297-6150
Contact:Principal Investigator: Anthony D. Elias
Porter Adventist Hospital
[Recruiting]
Denver, Colorado, United States, 80210
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Poudre Valley Hospital
[Recruiting]
Fort Collins, Colorado, United States, 80524
Contact:Contact: Anthony D. Elias 970-297-6150
Contact:Principal Investigator: Anthony D. Elias
Saint Anthony Hospital
[Recruiting]
Lakewood, Colorado, United States, 80228
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Littleton Adventist Hospital
[Recruiting]
Littleton, Colorado, United States, 80122
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Longmont United Hospital
[Recruiting]
Longmont, Colorado, United States, 80501
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
McKee Medical Center
[Recruiting]
Loveland, Colorado, United States, 80539
Contact:Contact: Keren Sturtz 303-777-2663 ccrp@co-cancerresearch.org
Contact:Principal Investigator: Keren Sturtz
Parker Adventist Hospital
[Recruiting]
Parker, Colorado, United States, 80138
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
United States, Connecticut
Greenwich Hospital
[Recruiting]
Greenwich, Connecticut, United States, 06830
Contact:Contact: Beverly J. Drucker 203-863-3698
Contact:Principal Investigator: Beverly J. Drucker
United States, Delaware
Helen F Graham Cancer Center
[Recruiting]
Newark, Delaware, United States, 19713
Contact:Contact: Gregory A. Masters 302-733-6227
Contact:Principal Investigator: Gregory A. Masters
Medical Oncology Hematology Consultants PA
[Recruiting]
Newark, Delaware, United States, 19713
Contact:Contact: Gregory A. Masters 302-733-6227
Contact:Principal Investigator: Gregory A. Masters
United States, District of Columbia
Sibley Memorial Hospital
[Recruiting]
Washington, D.C., District of Columbia, United States, 20016
Contact:Contact: Danijela Jelovac 410-955-8804 jhcccro@jhmi.edu
Contact:Principal Investigator: Danijela Jelovac
United States, Florida
UF Cancer Center at Orlando Health
[Recruiting]
Orlando, Florida, United States, 32806
Contact:Contact: Regan D. Rostorfer 321-841-7246 CancerClinicalTrials@orlandohealth.com
Contact:Principal Investigator: Regan D. Rostorfer
Sacred Heart Hospital
[Recruiting]
Pensacola, Florida, United States, 32504
Contact:Contact: Ranjith B. Dissanayake 850-416-4611 ttamayo@shhpens.org
Contact:Principal Investigator: Ranjith B. Dissanayake
United States, Georgia
Northside Hospital
[Recruiting]
Atlanta, Georgia, United States, 30342
Contact:Contact: Amelia B. Zelnak 404-778-1868
Contact:Principal Investigator: Amelia B. Zelnak
Dekalb Medical Center
[Recruiting]
Decatur, Georgia, United States, 30033
Contact:Contact: Sharad A. Ghamande 706-721-1663 cancer@augusta.edu
Contact:Principal Investigator: Sharad A. Ghamande
Gwinnett Medical Center
[Recruiting]
Lawrenceville, Georgia, United States, 30045
Contact:Contact: Aldemar Montero 678-312-2666
Contact:Principal Investigator: Aldemar Montero
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
[Recruiting]
Savannah, Georgia, United States, 31405
Contact:Contact: Howard A. Zaren 912-819-5704
Contact:Principal Investigator: Howard A. Zaren
South Georgia Medical Center/Pearlman Cancer Center
[Recruiting]
Valdosta, Georgia, United States, 31602
Contact:Contact: Samuel N. Ofori 229-259-4628 maryann.heddon@sgmc.org
Contact:Principal Investigator: Samuel N. Ofori
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise
[Recruiting]
Boise, Idaho, United States, 83706
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Saint Alphonsus Cancer Care Center-Caldwell
[Recruiting]
Caldwell, Idaho, United States, 83605
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Walter Knox Memorial Hospital
[Recruiting]
Emmett, Idaho, United States, 83617
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Idaho Urologic Institute-Meridian
[Recruiting]
Meridian, Idaho, United States, 83642
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Saint Alphonsus Medical Center-Nampa
[Recruiting]
Nampa, Idaho, United States, 83686
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
United States, Illinois
Illinois CancerCare-Bloomington
[Recruiting]
Bloomington, Illinois, United States, 61704
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Canton
[Recruiting]
Canton, Illinois, United States, 61520
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Carthage
[Recruiting]
Carthage, Illinois, United States, 62321
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Centralia Oncology Clinic
[Recruiting]
Centralia, Illinois, United States, 62801
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Northwestern University
[Recruiting]
Chicago, Illinois, United States, 60611
Contact:Contact: William J. Gradishar 312-695-1301 cancer@northwestern.edu
Contact:Principal Investigator: William J. Gradishar
Rush University Medical Center
[Recruiting]
Chicago, Illinois, United States, 60612
Contact:Contact: Melody A. Cobleigh 312-942-5498 clinical_trials@rush.edu
Contact:Principal Investigator: Melody A. Cobleigh
University of Chicago Comprehensive Cancer Center
[Recruiting]
Chicago, Illinois, United States, 60637
Contact:Contact: Rita Nanda 773-834-7424
Contact:Principal Investigator: Rita Nanda
Cancer Care Center of Decatur
[Recruiting]
Decatur, Illinois, United States, 62526
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Decatur Memorial Hospital
[Recruiting]
Decatur, Illinois, United States, 62526
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Crossroads Cancer Center
[Recruiting]
Effingham, Illinois, United States, 62401
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Eureka
[Recruiting]
Eureka, Illinois, United States, 61530
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Galesburg
[Recruiting]
Galesburg, Illinois, United States, 61401
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Northwestern Medicine Cancer Center Delnor
[Recruiting]
Geneva, Illinois, United States, 60134
Contact:Contact: John D. Ayers 847-827-9060
Contact:Principal Investigator: John D. Ayers
Illinois CancerCare-Kewanee Clinic
[Recruiting]
Kewanee, Illinois, United States, 61443
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Northwestern Medicine Lake Forest Hospital
[Recruiting]
Lake Forest, Illinois, United States, 60045
Contact:Contact: William J. Gradishar 312-695-1301 cancer@northwestern.edu
Contact:Principal Investigator: William J. Gradishar
Illinois CancerCare-Macomb
[Recruiting]
Macomb, Illinois, United States, 61455
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Loyola University Medical Center
[Recruiting]
Maywood, Illinois, United States, 60153
Contact:Contact: Kathy S. Albain 708-226-4357
Contact:Principal Investigator: Kathy S. Albain
Illinois CancerCare-Ottawa Clinic
[Recruiting]
Ottawa, Illinois, United States, 61350
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Pekin
[Recruiting]
Pekin, Illinois, United States, 61554
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Peoria
[Recruiting]
Peoria, Illinois, United States, 61615
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Peru
[Recruiting]
Peru, Illinois, United States, 61354
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Illinois CancerCare-Princeton
[Recruiting]
Princeton, Illinois, United States, 61356
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
SwedishAmerican Regional Cancer Center/ACT
[Recruiting]
Rockford, Illinois, United States, 61114
Contact:Contact: Harvey E. Einhorn 779-696-9400 cancercare@swedishamerican.org
Contact:Principal Investigator: Harvey E. Einhorn
Southern Illinois University School of Medicine
[Recruiting]
Springfield, Illinois, United States, 62702
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Springfield Clinic
[Recruiting]
Springfield, Illinois, United States, 62702
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Memorial Medical Center
[Recruiting]
Springfield, Illinois, United States, 62781
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Cancer Care Specialists of Illinois-Swansea
[Recruiting]
Swansea, Illinois, United States, 62226
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Northwestern Medicine Cancer Center Warrenville
[Recruiting]
Warrenville, Illinois, United States, 60555
Contact:Contact: John D. Ayers 847-827-9060
Contact:Principal Investigator: John D. Ayers
United States, Indiana
Deaconess Clinic Downtown
[Recruiting]
Evansville, Indiana, United States, 47713
Contact:Contact: Kendrith M. Rowland 630-978-6212 Cancer.Research@rushcopley.com
Contact:Principal Investigator: Kendrith M. Rowland
Memorial Regional Cancer Center Day Road
[Recruiting]
Mishawaka, Indiana, United States, 46545
Contact:Contact: Thomas J. Reid 800-284-7370
Contact:Principal Investigator: Thomas J. Reid
Chancellor Center for Oncology
[Recruiting]
Newburgh, Indiana, United States, 47630
Contact:Contact: Kendrith M. Rowland 630-978-6212 Cancer.Research@rushcopley.com
Contact:Principal Investigator: Kendrith M. Rowland
Memorial Hospital of South Bend
[Recruiting]
South Bend, Indiana, United States, 46601
Contact:Contact: Thomas J. Reid 800-284-7370
Contact:Principal Investigator: Thomas J. Reid
United States, Iowa
Mary Greeley Medical Center
[Recruiting]
Ames, Iowa, United States, 50010
Contact:Contact: Joseph J. Merchant 515-239-2621
Contact:Principal Investigator: Joseph J. Merchant
McFarland Clinic PC-William R Bliss Cancer Center
[Recruiting]
Ames, Iowa, United States, 50010
Contact:Contact: Joseph J. Merchant 515-239-2621
Contact:Principal Investigator: Joseph J. Merchant
McFarland Clinic PC-Boone
[Recruiting]
Boone, Iowa, United States, 50036
Contact:Contact: Joseph J. Merchant 515-239-2621
Contact:Principal Investigator: Joseph J. Merchant
Medical Oncology and Hematology Associates-West Des Moines
[Recruiting]
Clive, Iowa, United States, 50325
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Mercy Cancer Center-West Lakes
[Recruiting]
Clive, Iowa, United States, 50325
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Greater Regional Medical Center
[Recruiting]
Creston, Iowa, United States, 50801
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Genesis Medical Center - East Campus
[Recruiting]
Davenport, Iowa, United States, 52803
Contact:Contact: George Kovach 800-446-6088 werners@genesishealth.com
Contact:Principal Investigator: George Kovach
Iowa Methodist Medical Center
[Recruiting]
Des Moines, Iowa, United States, 50309
Contact:Contact: Robert J. Behrens 515-239-2621
Contact:Principal Investigator: Robert J. Behrens
Medical Oncology and Hematology Associates-Des Moines
[Recruiting]
Des Moines, Iowa, United States, 50309
Contact:Contact: Robert J. Behrens 515-239-2621
Contact:Principal Investigator: Robert J. Behrens
Broadlawns Medical Center
[Recruiting]
Des Moines, Iowa, United States, 50314
Contact:Contact: Robert J. Behrens 515-239-2621
Contact:Principal Investigator: Robert J. Behrens
Medical Oncology and Hematology Associates-Laurel
[Recruiting]
Des Moines, Iowa, United States, 50314
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Mercy Medical Center - Des Moines
[Recruiting]
Des Moines, Iowa, United States, 50314
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Iowa Lutheran Hospital
[Recruiting]
Des Moines, Iowa, United States, 50316
Contact:Contact: Robert J. Behrens 515-239-2621
Contact:Principal Investigator: Robert J. Behrens
McFarland Clinic PC-Trinity Cancer Center
[Recruiting]
Fort Dodge, Iowa, United States, 50501
Contact:Contact: Joseph J. Merchant 515-239-2621
Contact:Principal Investigator: Joseph J. Merchant
McFarland Clinic PC-Jefferson
[Recruiting]
Jefferson, Iowa, United States, 50129
Contact:Contact: Joseph J. Merchant 515-239-2621
Contact:Principal Investigator: Joseph J. Merchant
McFarland Clinic PC-Marshalltown
[Recruiting]
Marshalltown, Iowa, United States, 50158
Contact:Contact: Joseph J. Merchant 515-239-2621
Contact:Principal Investigator: Joseph J. Merchant
Methodist West Hospital
[Recruiting]
West Des Moines, Iowa, United States, 50266-7700
Contact:Contact: Robert J. Behrens 515-239-2621
Contact:Principal Investigator: Robert J. Behrens
Mercy Medical Center-West Lakes
[Recruiting]
West Des Moines, Iowa, United States, 50266
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
United States, Kansas
Cancer Center of Kansas - Chanute
[Recruiting]
Chanute, Kansas, United States, 66720
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Dodge City
[Recruiting]
Dodge City, Kansas, United States, 67801
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Fort Scott
[Recruiting]
Fort Scott, Kansas, United States, 66701
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
University of Kansas Cancer Center
[Recruiting]
Kansas City, Kansas, United States, 66160
Contact:Contact: Joshua M. Mammen 913-945-7552 ctnursenav@kumc.edu
Contact:Principal Investigator: Joshua M. Mammen
Cancer Center of Kansas-Kingman
[Recruiting]
Kingman, Kansas, United States, 67068
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Lawrence Memorial Hospital
[Recruiting]
Lawrence, Kansas, United States, 66044
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas-Liberal
[Recruiting]
Liberal, Kansas, United States, 67905
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - McPherson
[Recruiting]
McPherson, Kansas, United States, 67460
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Newton
[Recruiting]
Newton, Kansas, United States, 67114
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Parsons
[Recruiting]
Parsons, Kansas, United States, 67357
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Pratt
[Recruiting]
Pratt, Kansas, United States, 67124
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Wellington
[Recruiting]
Wellington, Kansas, United States, 67152
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
University of Kansas Hospital-Westwood Cancer Center
[Recruiting]
Westwood, Kansas, United States, 66205
Contact:Contact: Joshua M. Mammen 913-945-7552 ctnursenav@kumc.edu
Contact:Principal Investigator: Joshua M. Mammen
Cancer Center of Kansas-Wichita Medical Arts Tower
[Recruiting]
Wichita, Kansas, United States, 67208
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Wichita
[Recruiting]
Wichita, Kansas, United States, 67214
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Via Christi Regional Medical Center
[Recruiting]
Wichita, Kansas, United States, 67214
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
Cancer Center of Kansas - Winfield
[Recruiting]
Winfield, Kansas, United States, 67156
Contact:Contact: Shaker R. Dakhil 316-268-5374
Contact:Principal Investigator: Shaker R. Dakhil
United States, Kentucky
Saint Joseph Hospital East
[Recruiting]
Lexington, Kentucky, United States, 40509
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
University of Kentucky/Markey Cancer Center
[Recruiting]
Lexington, Kentucky, United States, 40536
Contact:Contact: Mara D. Chambers 859-257-3379
Contact:Principal Investigator: Mara D. Chambers
United States, Louisiana
Christus Saint Frances Cabrini Hospital
[Recruiting]
Alexandria, Louisiana, United States, 71301
Contact:Contact: John T. Cole 504-842-3708
Contact:Principal Investigator: John T. Cole
LSU Health Baton Rouge-North Clinic
[Recruiting]
Baton Rouge, Louisiana, United States, 70805
Contact:Contact: David S. Hanson 225-215-1353 clinicalresearch@marybird.com
Contact:Principal Investigator: David S. Hanson
Hematology/Oncology Clinic LLP
[Recruiting]
Baton Rouge, Louisiana, United States, 70809
Contact:Contact: Hana F. Safah 504-988-6121
Contact:Principal Investigator: Hana F. Safah
Louisiana Hematology Oncology Associates LLC
[Recruiting]
Baton Rouge, Louisiana, United States, 70809
Contact:Contact: David S. Hanson 225-215-1353 clinicalresearch@marybird.com
Contact:Principal Investigator: David S. Hanson
Mary Bird Perkins Cancer Center
[Recruiting]
Baton Rouge, Louisiana, United States, 70809
Contact:Contact: David S. Hanson 225-215-1353 clinicalresearch@marybird.com
Contact:Principal Investigator: David S. Hanson
Medical Oncology LLC
[Recruiting]
Baton Rouge, Louisiana, United States, 70809
Contact:Contact: David S. Hanson 225-215-1353 clinicalresearch@marybird.com
Contact:Principal Investigator: David S. Hanson
Ochsner Health Center-Summa
[Recruiting]
Baton Rouge, Louisiana, United States, 70809
Contact:Contact: John T. Cole 504-842-3708
Contact:Principal Investigator: John T. Cole
North Shore Hematology Oncology Associates Inc
[Recruiting]
Covington, Louisiana, United States, 70433
Contact:Contact: David S. Hanson 225-215-1353 clinicalresearch@marybird.com
Contact:Principal Investigator: David S. Hanson
Oncology Center of The South Incorporated
[Recruiting]
Houma, Louisiana, United States, 70360
Contact:Contact: David S. Hanson 225-215-1353 clinicalresearch@marybird.com
Contact:Principal Investigator: David S. Hanson
Ochsner Medical Center Kenner
[Recruiting]
Kenner, Louisiana, United States, 70065
Contact:Contact: John T. Cole 504-842-3708
Contact:Principal Investigator: John T. Cole
CHRISTUS Saint Patrick Hospital
[Recruiting]
Lake Charles, Louisiana, United States, 70601
Contact:Contact: John T. Cole 504-842-3708
Contact:Principal Investigator: John T. Cole
Ochsner Medical Center Jefferson
[Recruiting]
New Orleans, Louisiana, United States, 70121
Contact:Contact: John T. Cole 504-842-3708
Contact:Principal Investigator: John T. Cole
United States, Maine
York Hospital
[Recruiting]
York, Maine, United States, 03909
Contact:Contact: Marilyn A. McLaughlin 207-351-3777
Contact:Principal Investigator: Marilyn A. McLaughlin
United States, Maryland
Mercy Medical Center
[Recruiting]
Baltimore, Maryland, United States, 21202
Contact:Contact: David A. Riseberg 410-951-7950 prc@mdmercy.com
Contact:Principal Investigator: David A. Riseberg
Greater Baltimore Medical Center
[Recruiting]
Baltimore, Maryland, United States, 21204
Contact:Contact: Robert B. Donegan 443-849-3706
Contact:Principal Investigator: Robert B. Donegan
Saint Agnes Hospital
[Recruiting]
Baltimore, Maryland, United States, 21229
Contact:Contact: Diana H. Griffiths 410-368-2910
Contact:Principal Investigator: Diana H. Griffiths
Johns Hopkins University/Sidney Kimmel Cancer Center
[Recruiting]
Baltimore, Maryland, United States, 21287
Contact:Contact: Danijela Jelovac 410-955-8804 jhcccro@jhmi.edu
Contact:Principal Investigator: Danijela Jelovac
Frederick Memorial Hospital
[Recruiting]
Frederick, Maryland, United States, 21701
Contact:Contact: Brian M. O'Connor 240-566-3584 clinicaltrials@fmh.org
Contact:Principal Investigator: Brian M. O'Connor
United States, Massachusetts
Boston Medical Center
[Recruiting]
Boston, Massachusetts, United States, 02118
Contact:Contact: Lauren J. Oshry 617-638-8265
Contact:Principal Investigator: Lauren J. Oshry
Lahey Hospital and Medical Center
[Recruiting]
Burlington, Massachusetts, United States, 01805
Contact:Contact: Corrine L. Zarwan 781-744-8027
Contact:Principal Investigator: Corrine L. Zarwan
Lowell General Hospital
[Recruiting]
Lowell, Massachusetts, United States, 01854
Contact:Contact: Richard M. Zuniga 978-788-7084 ghincks@lowellgeneral.org
Contact:Principal Investigator: Richard M. Zuniga
United States, Michigan
Saint Joseph Mercy Hospital
[Recruiting]
Ann Arbor, Michigan, United States, 48106-0995
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
University of Michigan Comprehensive Cancer Center
[Recruiting]
Ann Arbor, Michigan, United States, 48109
Contact:Contact: Anne F. Schott 800-865-1125
Contact:Principal Investigator: Anne F. Schott
IHA Hematology Oncology Consultants-Brighton
[Recruiting]
Brighton, Michigan, United States, 48114
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Henry Ford Cancer Institute¿Downriver
[Recruiting]
Brownstown Charter Township, Michigan, United States, 48183
Contact:Contact: Robert A. Chapman 313-916-1784
Contact:Principal Investigator: Robert A. Chapman
Caro Cancer Center
[Recruiting]
Caro, Michigan, United States, 48723
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
IHA Hematology Oncology Consultants-Chelsea
[Recruiting]
Chelsea, Michigan, United States, 48118
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Hematology Oncology Consultants-Clarkston
[Recruiting]
Clarkston, Michigan, United States, 48346
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Newland Medical Associates-Clarkston
[Recruiting]
Clarkston, Michigan, United States, 48346
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Henry Ford Macomb Hospital-Clinton Township
[Recruiting]
Clinton, Michigan, United States, 48038
Contact:Contact: Robert A. Chapman 313-916-1784
Contact:Principal Investigator: Robert A. Chapman
Henry Ford Medical Center-Fairlane
[Recruiting]
Dearborn, Michigan, United States, 48126
Contact:Contact: Robert A. Chapman 313-916-1784
Contact:Principal Investigator: Robert A. Chapman
Henry Ford Hospital
[Recruiting]
Detroit, Michigan, United States, 48202
Contact:Contact: Robert A. Chapman 313-916-1784
Contact:Principal Investigator: Robert A. Chapman
Saint John Hospital and Medical Center
[Recruiting]
Detroit, Michigan, United States, 48236
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Michigan State University Clinical Center
[Recruiting]
East Lansing, Michigan, United States, 48824-7016
Contact:Contact: Deimante M. Tamkus 517-975-9547
Contact:Principal Investigator: Deimante M. Tamkus
Hurley Medical Center
[Recruiting]
Flint, Michigan, United States, 48502
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Genesee Cancer and Blood Disease Treatment Center
[Recruiting]
Flint, Michigan, United States, 48503
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Genesee Hematology Oncology PC
[Recruiting]
Flint, Michigan, United States, 48503
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Genesys Hurley Cancer Institute
[Recruiting]
Flint, Michigan, United States, 48503
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Mercy Health Saint Mary's
[Recruiting]
Grand Rapids, Michigan, United States, 49503
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Spectrum Health at Butterworth Campus
[Recruiting]
Grand Rapids, Michigan, United States, 49503
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
[Recruiting]
Grosse Pointe Woods, Michigan, United States, 48236
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
West Michigan Cancer Center
[Recruiting]
Kalamazoo, Michigan, United States, 49007
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Sparrow Hospital
[Recruiting]
Lansing, Michigan, United States, 48912
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Saint Mary Mercy Hospital
[Recruiting]
Livonia, Michigan, United States, 48154
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Hematology Oncology Associates East PC
[Recruiting]
Macomb, Michigan, United States, 48044
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Mid-Michigan Medical Center - Midland
[Recruiting]
Midland, Michigan, United States, 48670
Contact:Contact: Michel R. Hurtubise 989-839-3377
Contact:Principal Investigator: Michel R. Hurtubise
Monroe Cancer Center
[Recruiting]
Monroe, Michigan, United States, 48162
Contact:Contact: Jeffrey H. Muler 419-824-1842
Contact:Principal Investigator: Jeffrey H. Muler
Mercy Health Mercy Campus
[Recruiting]
Muskegon, Michigan, United States, 49444
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Assarian Cancer Center
[Recruiting]
Novi, Michigan, United States, 48374-1236
Contact:Contact: Cynthia M. Vakhariya 248-849-5337 jaswinder.grewal@stjohn.org
Contact:Principal Investigator: Cynthia M. Vakhariya
Henry Ford Medical Center-Columbus
[Recruiting]
Novi, Michigan, United States, 48377
Contact:Contact: Robert A. Chapman 313-916-1784
Contact:Principal Investigator: Robert A. Chapman
21st Century Oncology-Pontiac
[Recruiting]
Pontiac, Michigan, United States, 48341
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Hope Cancer Center
[Recruiting]
Pontiac, Michigan, United States, 48341
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Newland Medical Associates-Pontiac
[Recruiting]
Pontiac, Michigan, United States, 48341
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Saint Joseph Mercy Oakland
[Recruiting]
Pontiac, Michigan, United States, 48341
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Spectrum Health Reed City Hospital
[Recruiting]
Reed City, Michigan, United States, 49677
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Saint Mary's of Michigan
[Recruiting]
Saginaw, Michigan, United States, 48601
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Oncology Hematology Associates of Saginaw Valley PC
[Recruiting]
Saginaw, Michigan, United States, 48604
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Marie Yeager Cancer Center
[Recruiting]
Saint Joseph, Michigan, United States, 49085
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Providence Hospital-Southfield Cancer Center
[Recruiting]
Southfield, Michigan, United States, 48075
Contact:Contact: Cynthia M. Vakhariya 248-849-5337 jaswinder.grewal@stjohn.org
Contact:Principal Investigator: Cynthia M. Vakhariya
Munson Medical Center
[Recruiting]
Traverse City, Michigan, United States, 49684
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
Great Lakes Cancer Management Specialists-Macomb Professional Building
[Recruiting]
Warren, Michigan, United States, 48093
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Saint John Macomb-Oakland Hospital
[Recruiting]
Warren, Michigan, United States, 48093
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Henry Ford West Bloomfield Hospital
[Recruiting]
West Bloomfield Township, Michigan, United States, 48322
Contact:Contact: Robert A. Chapman 313-916-1784
Contact:Principal Investigator: Robert A. Chapman
Saint Mary's Oncology/Hematology Associates of West Branch
[Recruiting]
West Branch, Michigan, United States, 48661
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Metro Health Hospital
[Recruiting]
Wyoming, Michigan, United States, 49519
Contact:Contact: Kathleen J. Yost 616-391-1230 crcwm-regulatory@crcwm.org
Contact:Principal Investigator: Kathleen J. Yost
IHA Hematology Oncology Consultants-Ann Arbor
[Recruiting]
Ypsilanti, Michigan, United States, 48197
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
United States, Minnesota
Sanford Clinic North-Bemidgi
[Recruiting]
Bemidji, Minnesota, United States, 56601
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
Fairview Ridges Hospital
[Recruiting]
Burnsville, Minnesota, United States, 55337
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Mercy Hospital
[Recruiting]
Coon Rapids, Minnesota, United States, 55433
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Essentia Health Cancer Center
[Recruiting]
Duluth, Minnesota, United States, 55805
Contact:Contact: Bret E. Friday 888-203-7267
Contact:Principal Investigator: Bret E. Friday
Essentia Health Saint Mary's Medical Center
[Recruiting]
Duluth, Minnesota, United States, 55805
Contact:Contact: Bret E. Friday 888-203-7267
Contact:Principal Investigator: Bret E. Friday
Miller-Dwan Hospital
[Recruiting]
Duluth, Minnesota, United States, 55805
Contact:Contact: Bret E. Friday 888-203-7267
Contact:Principal Investigator: Bret E. Friday
Fairview-Southdale Hospital
[Recruiting]
Edina, Minnesota, United States, 55435
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Unity Hospital
[Recruiting]
Fridley, Minnesota, United States, 55432
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Fairview Maple Grove Medical Center
[Recruiting]
Maple Grove, Minnesota, United States, 55369
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Minnesota Oncology Hematology PA-Maplewood
[Recruiting]
Maplewood, Minnesota, United States, 55109
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Saint John's Hospital - Healtheast
[Recruiting]
Maplewood, Minnesota, United States, 55109
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Abbott-Northwestern Hospital
[Recruiting]
Minneapolis, Minnesota, United States, 55407
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Hennepin County Medical Center
[Recruiting]
Minneapolis, Minnesota, United States, 55415
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Health Partners Inc
[Recruiting]
Minneapolis, Minnesota, United States, 55454
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
New Ulm Medical Center
[Recruiting]
New Ulm, Minnesota, United States, 56073
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
North Memorial Medical Health Center
[Recruiting]
Robbinsdale, Minnesota, United States, 55422
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Park Nicollet Clinic - Saint Louis Park
[Recruiting]
Saint Louis Park, Minnesota, United States, 55416
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Regions Hospital
[Recruiting]
Saint Paul, Minnesota, United States, 55101
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
United Hospital
[Recruiting]
Saint Paul, Minnesota, United States, 55102
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Saint Francis Regional Medical Center
[Recruiting]
Shakopee, Minnesota, United States, 55379
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Lakeview Hospital
[Recruiting]
Stillwater, Minnesota, United States, 55082
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Ridgeview Medical Center
[Recruiting]
Waconia, Minnesota, United States, 55387
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Rice Memorial Hospital
[Recruiting]
Willmar, Minnesota, United States, 56201
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Minnesota Oncology Hematology PA-Woodbury
[Recruiting]
Woodbury, Minnesota, United States, 55125
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
Fairview Lakes Medical Center
[Recruiting]
Wyoming, Minnesota, United States, 55092
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
United States, Missouri
Saint Francis Medical Center
[Recruiting]
Cape Girardeau, Missouri, United States, 63703
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
Missouri Baptist Medical Center
[Recruiting]
Saint Louis, Missouri, United States, 63131
Contact:Contact: James L. Wade 309-243-3605
Contact:Principal Investigator: James L. Wade
United States, Nebraska
CHI Health Saint Francis
[Recruiting]
Grand Island, Nebraska, United States, 68803
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
United States, New Hampshire
Dartmouth Hitchcock Medical Center
[Recruiting]
Lebanon, New Hampshire, United States, 03756
Contact:Contact: Mary D. Chamberlin 603-354-5454 Ext. 2155 jmichelson@cheshire-med.com
Contact:Principal Investigator: Mary D. Chamberlin
Norris Cotton Cancer Center-Manchester
[Recruiting]
Manchester, New Hampshire, United States, 03102
Contact:Contact: Mary D. Chamberlin 603-354-5454 Ext. 2155 jmichelson@cheshire-med.com
Contact:Principal Investigator: Mary D. Chamberlin
Saint Joseph Hospital
[Recruiting]
Nashua, New Hampshire, United States, 03060
Contact:Contact: Umit Tapan 603-880-3408 carcieri@sjh-nh.org
Contact:Principal Investigator: Umit Tapan
Norris Cotton Cancer Center-Nashua
[Recruiting]
Nashua, New Hampshire, United States, 03063
Contact:Contact: Mary D. Chamberlin 603-354-5454 Ext. 2155 jmichelson@cheshire-med.com
Contact:Principal Investigator: Mary D. Chamberlin
United States, New Jersey
Hackensack University Medical Center
[Recruiting]
Hackensack, New Jersey, United States, 07601
Contact:Contact: Deena M. Graham 201-996-2879
Contact:Principal Investigator: Deena M. Graham
Saint Barnabas Medical Center
[Recruiting]
Livingston, New Jersey, United States, 07039
Contact:Contact: Anna M. Litvak 973-322-2470
Contact:Principal Investigator: Anna M. Litvak
Monmouth Medical Center
[Recruiting]
Long Branch, New Jersey, United States, 07740
Contact:Contact: Seth D. Cohen 732-923-7689
Contact:Principal Investigator: Seth D. Cohen
Virtua Memorial
[Recruiting]
Mount Holly, New Jersey, United States, 08060
Contact:Contact: James W. Lee 609-914-6762
Contact:Principal Investigator: James W. Lee
Virtua Voorhees
[Recruiting]
Voorhees, New Jersey, United States, 08043
Contact:Contact: James W. Lee 609-914-6762
Contact:Principal Investigator: James W. Lee
United States, New Mexico
Lovelace Medical Center-Saint Joseph Square
[Recruiting]
Albuquerque, New Mexico, United States, 87102
Contact:Contact: Ursa A. Brown-Glaberman 505-925-0366 LByatt@nmcca.org
Contact:Principal Investigator: Ursa A. Brown-Glaberman
University of New Mexico Cancer Center
[Recruiting]
Albuquerque, New Mexico, United States, 87102
Contact:Contact: Ursa A. Brown-Glaberman 505-925-0366 LByatt@nmcca.org
Contact:Principal Investigator: Ursa A. Brown-Glaberman
New Mexico Oncology Hematology Consultants
[Recruiting]
Albuquerque, New Mexico, United States, 87109
Contact:Contact: Ursa A. Brown-Glaberman 505-925-0366 LByatt@nmcca.org
Contact:Principal Investigator: Ursa A. Brown-Glaberman
Presbyterian Kaseman Hospital
[Recruiting]
Albuquerque, New Mexico, United States, 87110
Contact:Contact: Ursa A. Brown-Glaberman 505-925-0366 LByatt@nmcca.org
Contact:Principal Investigator: Ursa A. Brown-Glaberman
Memorial Medical Center - Las Cruces
[Recruiting]
Las Cruces, New Mexico, United States, 88011
Contact:Contact: Ursa A. Brown-Glaberman 505-925-0366 LByatt@nmcca.org
Contact:Principal Investigator: Ursa A. Brown-Glaberman
Christus Saint Vincent Regional Cancer Center
[Recruiting]
Santa Fe, New Mexico, United States, 87505
Contact:Contact: Ursa A. Brown-Glaberman 505-925-0366 LByatt@nmcca.org
Contact:Principal Investigator: Ursa A. Brown-Glaberman
United States, New York
Roswell Park Cancer Institute
[Recruiting]
Buffalo, New York, United States, 14263
Contact:Contact: Ellis G. Levine 877-275-7724
Contact:Principal Investigator: Ellis G. Levine
Arnot Ogden Medical Center/Falck Cancer Center
[Recruiting]
Elmira, New York, United States, 14905
Contact:Contact: Serge Dauphin 607-271-7000
Contact:Principal Investigator: Serge Dauphin
Orange Regional Medical Center
[Recruiting]
Middletown, New York, United States, 10940
Contact:Contact: Jeffrey M. Stewart 845-342-7609
Contact:Principal Investigator: Jeffrey M. Stewart
NYU Winthrop Hospital
[Recruiting]
Mineola, New York, United States, 11501
Contact:Contact: Nina D'Abreo 516-663-3115
Contact:Principal Investigator: Nina D'Abreo
Laura and Isaac Perlmutter Cancer Center at NYU Langone
[Recruiting]
New York, New York, United States, 10016
Contact:Contact: Sylvia Adams 212-263-4434 prmc.coordinator@nyumc.org
Contact:Principal Investigator: Sylvia Adams
Columbia University/Herbert Irving Cancer Center
[Recruiting]
New York, New York, United States, 10032
Contact:Contact: Meghna S. Trivedi 212-305-8615
Contact:Principal Investigator: Meghna S. Trivedi
Weill Medical College of Cornell University
[Recruiting]
New York, New York, United States, 10065
Contact:Contact: Eleni Andreopoulou 212-746-1848
Contact:Principal Investigator: Eleni Andreopoulou
Dickstein Cancer Treatment Center
[Recruiting]
White Plains, New York, United States, 10601
Contact:Contact: Dan Costin 914-849-7582 mcortese@wphospital.org
Contact:Principal Investigator: Dan Costin
United States, North Carolina
Randolph Hospital
[Recruiting]
Asheboro, North Carolina, United States, 27203
Contact:Contact: Vinay K. Gudena 336-832-0821
Contact:Principal Investigator: Vinay K. Gudena
Cone Health Cancer Center at Alamance Regional
[Recruiting]
Burlington, North Carolina, United States, 27215
Contact:Contact: Vinay K. Gudena 336-832-0821
Contact:Principal Investigator: Vinay K. Gudena
UNC Lineberger Comprehensive Cancer Center
[Recruiting]
Chapel Hill, North Carolina, United States, 27599
Contact:Contact: Elizabeth C. Dees 877-668-0683 cancerclinicaltrials@med.unc.edu
Contact:Principal Investigator: Elizabeth C. Dees
Novant Health Presbyterian Medical Center
[Recruiting]
Charlotte, North Carolina, United States, 28204
Contact:Contact: Nasfat Shehadeh 704-384-5369
Contact:Principal Investigator: Nasfat Shehadeh
Oncology Specialists of Charlotte
[Recruiting]
Charlotte, North Carolina, United States, 28207
Contact:Contact: Nasfat Shehadeh 704-384-5369
Contact:Principal Investigator: Nasfat Shehadeh
Southeastern Medical Oncology Center-Clinton
[Recruiting]
Clinton, North Carolina, United States, 28328
Contact:Contact: James N. Atkins 252-399-7491
Contact:Principal Investigator: James N. Atkins
Southeastern Medical Oncology Center-Goldsboro
[Recruiting]
Goldsboro, North Carolina, United States, 27534
Contact:Contact: James N. Atkins 252-399-7491
Contact:Principal Investigator: James N. Atkins
Cone Health Cancer Center
[Recruiting]
Greensboro, North Carolina, United States, 27403
Contact:Contact: Vinay K. Gudena 336-832-0821
Contact:Principal Investigator: Vinay K. Gudena
Margaret R Pardee Memorial Hospital
[Recruiting]
Hendersonville, North Carolina, United States, 28791
Contact:Contact: James E. Radford 828-696-1341
Contact:Principal Investigator: James E. Radford
Lake Norman Hematology Oncology Specialists-Huntersville
[Recruiting]
Huntersville, North Carolina, United States, 28078
Contact:Contact: Nasfat Shehadeh 704-384-5369
Contact:Principal Investigator: Nasfat Shehadeh
Southern Oncology Specialists-Huntersville
[Recruiting]
Huntersville, North Carolina, United States, 28078
Contact:Contact: Nasfat Shehadeh 704-384-5369
Contact:Principal Investigator: Nasfat Shehadeh
Southeastern Medical Oncology Center-Jacksonville
[Recruiting]
Jacksonville, North Carolina, United States, 28546
Contact:Contact: James N. Atkins 252-399-7491
Contact:Principal Investigator: James N. Atkins
Novant Health Cancer Specialists-Matthews
[Suspended]
Matthews, North Carolina, United States, 28105
Cone Heath Cancer Center at Mebane
[Recruiting]
Mebane, North Carolina, United States, 27302
Contact:Contact: Vinay K. Gudena 336-832-0821
Contact:Principal Investigator: Vinay K. Gudena
Lake Norman Hematology Oncology Specialists-Mooresville
[Recruiting]
Mooresville, North Carolina, United States, 28117
Contact:Contact: Nasfat Shehadeh 704-384-5369
Contact:Principal Investigator: Nasfat Shehadeh
Annie Penn Memorial Hospital
[Recruiting]
Reidsville, North Carolina, United States, 27320
Contact:Contact: Vinay K. Gudena 336-832-0821
Contact:Principal Investigator: Vinay K. Gudena
United States, North Dakota
Sanford Bismarck Medical Center
[Recruiting]
Bismarck, North Dakota, United States, 58501
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
Roger Maris Cancer Center
[Recruiting]
Fargo, North Dakota, United States, 58122
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
Sanford Broadway Medical Center
[Recruiting]
Fargo, North Dakota, United States, 58122
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
Sanford Clinic North-Fargo
[Recruiting]
Fargo, North Dakota, United States, 58122
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
United States, Ohio
UHHS-Chagrin Highlands Medical Center
[Recruiting]
Beachwood, Ohio, United States, 44122
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Strecker Cancer Center-Belpre
[Recruiting]
Belpre, Ohio, United States, 45714
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Adena Regional Medical Center
[Recruiting]
Chillicothe, Ohio, United States, 45601
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Case Western Reserve University
[Recruiting]
Cleveland, Ohio, United States, 44106
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Ohio State University Comprehensive Cancer Center
[Recruiting]
Columbus, Ohio, United States, 43210
Contact:Contact: Sagar D. Sardesai 800-293-5066 Jamesline@osumc.edu
Contact:Principal Investigator: Sagar D. Sardesai
Mount Carmel East Hospital
[Recruiting]
Columbus, Ohio, United States, 43213
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Columbus Oncology and Hematology Associates Inc
[Recruiting]
Columbus, Ohio, United States, 43214
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Riverside Methodist Hospital
[Recruiting]
Columbus, Ohio, United States, 43214
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Grant Medical Center
[Recruiting]
Columbus, Ohio, United States, 43215
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
The Mark H Zangmeister Center
[Recruiting]
Columbus, Ohio, United States, 43219
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Mount Carmel Health Center West
[Recruiting]
Columbus, Ohio, United States, 43222
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Doctors Hospital
[Recruiting]
Columbus, Ohio, United States, 43228
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Delaware Health Center-Grady Cancer Center
[Recruiting]
Delaware, Ohio, United States, 43015
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Grady Memorial Hospital
[Recruiting]
Delaware, Ohio, United States, 43015
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Mercy Cancer Center-Elyria
[Recruiting]
Elyria, Ohio, United States, 44035
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
OhioHealth Mansfield Hospital
[Recruiting]
Mansfield, Ohio, United States, 44903
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Marietta Memorial Hospital
[Recruiting]
Marietta, Ohio, United States, 45750
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
OneHealth Marion General Hospital
[Recruiting]
Marion, Ohio, United States, 43302
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Lake University Ireland Cancer Center
[Recruiting]
Mentor, Ohio, United States, 44060
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Southwest General Health Center Ireland Cancer Center
[Recruiting]
Middleburg Heights, Ohio, United States, 44130
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Knox Community Hospital
[Recruiting]
Mount Vernon, Ohio, United States, 43050
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Licking Memorial Hospital
[Recruiting]
Newark, Ohio, United States, 43055
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
University Hospitals Parma Medical Center
[Recruiting]
Parma, Ohio, United States, 44129
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Southern Ohio Medical Center
[Recruiting]
Portsmouth, Ohio, United States, 45662
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
Ireland Cancer Center at Firelands Regional Medical Center
[Recruiting]
Sandusky, Ohio, United States, 44870
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Flower Hospital
[Recruiting]
Sylvania, Ohio, United States, 43560
Contact:Contact: Jeffrey H. Muler 419-824-1842
Contact:Principal Investigator: Jeffrey H. Muler
The Toledo Hospital/Toledo Children's Hospital
[Recruiting]
Toledo, Ohio, United States, 43606
Contact:Contact: Jeffrey H. Muler 419-824-1842
Contact:Principal Investigator: Jeffrey H. Muler
University Hospitals Sharon Health Center
[Recruiting]
Wadsworth, Ohio, United States, 44281
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Saint Ann's Hospital
[Recruiting]
Westerville, Ohio, United States, 43081
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
UH-Seidman Cancer Center at Saint John Medical Center
[Recruiting]
Westlake, Ohio, United States, 44145
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
UHHS-Westlake Medical Center
[Recruiting]
Westlake, Ohio, United States, 44145
Contact:Contact: Shaveta Vinayak 800-641-2422
Contact:Principal Investigator: Shaveta Vinayak
Genesis Healthcare System Cancer Care Center
[Recruiting]
Zanesville, Ohio, United States, 43701
Contact:Contact: Timothy D. Moore 614-488-2745 sheree@columbusccop.org
Contact:Principal Investigator: Timothy D. Moore
United States, Oklahoma
University of Oklahoma Health Sciences Center
[Recruiting]
Oklahoma City, Oklahoma, United States, 73104
Contact:Contact: Wajeeha Razaq 402-559-6941 unmcrsa@unmc.edu
Contact:Principal Investigator: Wajeeha Razaq
United States, Oregon
Saint Alphonsus Medical Center-Baker City
[Recruiting]
Baker City, Oregon, United States, 97814
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Providence Oncology and Hematology Care Southeast
[Recruiting]
Clackamas, Oregon, United States, 97015
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Good Samaritan Hospital
[Recruiting]
Corvallis, Oregon, United States, 97330
Contact:Contact: David M. Hufnagel 541-768-4352 stmock@samhealth.org
Contact:Principal Investigator: David M. Hufnagel
Providence Newberg Medical Center
[Recruiting]
Newberg, Oregon, United States, 97132
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Saint Alphonsus Medical Center-Ontario
[Recruiting]
Ontario, Oregon, United States, 97914
Contact:Contact: Christopher M. Reynolds 208-367-7954
Contact:Principal Investigator: Christopher M. Reynolds
Providence Portland Medical Center
[Recruiting]
Portland, Oregon, United States, 97213
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Providence Saint Vincent Medical Center
[Recruiting]
Portland, Oregon, United States, 97225
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Kaiser Permanente Northwest
[Recruiting]
Portland, Oregon, United States, 97227
Contact:Contact: Sandeep H. Mashru 503-335-2400
Contact:Principal Investigator: Sandeep H. Mashru
SWOG
[Recruiting]
Portland, Oregon, United States, 97239
Contact:Contact: Lajos Pusztai 203-785-5702
Contact:Principal Investigator: Lajos Pusztai
United States, Pennsylvania
Bryn Mawr Hospital
[Recruiting]
Bryn Mawr, Pennsylvania, United States, 19010
Contact:Contact: Albert S. DeNittis 484-476-2649 ewend@mlhs.org
Contact:Principal Investigator: Albert S. DeNittis
Jefferson Hospital
[Recruiting]
Jefferson Hills, Pennsylvania, United States, 15025
Contact:Contact: Christie J. Hilton 724-226-7380
Contact:Principal Investigator: Christie J. Hilton
Riddle Memorial Hospital
[Recruiting]
Media, Pennsylvania, United States, 19063
Contact:Contact: Albert S. DeNittis 484-476-2649 ewend@mlhs.org
Contact:Principal Investigator: Albert S. DeNittis
Forbes Hospital
[Recruiting]
Monroeville, Pennsylvania, United States, 15146
Contact:Contact: Christie J. Hilton 724-226-7380
Contact:Principal Investigator: Christie J. Hilton
Paoli Memorial Hospital
[Recruiting]
Paoli, Pennsylvania, United States, 19301
Contact:Contact: Albert S. DeNittis 484-476-2649 ewend@mlhs.org
Contact:Principal Investigator: Albert S. DeNittis
Thomas Jefferson University Hospital
[Recruiting]
Philadelphia, Pennsylvania, United States, 19107
Contact:Contact: Maysa M. Abu-Khalaf 215-955-6084
Contact:Principal Investigator: Maysa M. Abu-Khalaf
Allegheny General Hospital
[Recruiting]
Pittsburgh, Pennsylvania, United States, 15212
Contact:Contact: Christie J. Hilton 724-226-7380
Contact:Principal Investigator: Christie J. Hilton
West Penn Hospital
[Recruiting]
Pittsburgh, Pennsylvania, United States, 15224
Contact:Contact: Christie J. Hilton 724-226-7380
Contact:Principal Investigator: Christie J. Hilton
University of Pittsburgh Cancer Institute (UPCI)
[Recruiting]
Pittsburgh, Pennsylvania, United States, 15232
Contact:Contact: Rachel C. Jankowitz 412-647-2811
Contact:Principal Investigator: Rachel C. Jankowitz
Reading Hospital
[Recruiting]
West Reading, Pennsylvania, United States, 19611
Contact:Contact: Terrence P. Cescon 610-988-9323
Contact:Principal Investigator: Terrence P. Cescon
Wexford Health and Wellness Pavilion
[Recruiting]
Wexford, Pennsylvania, United States, 15090
Contact:Contact: Christie J. Hilton 724-226-7380
Contact:Principal Investigator: Christie J. Hilton
UPMC Susquehanna
[Recruiting]
Williamsport, Pennsylvania, United States, 17701
Contact:Contact: Warren L. Robinson 412-647-8073
Contact:Principal Investigator: Warren L. Robinson
Lankenau Medical Center
[Recruiting]
Wynnewood, Pennsylvania, United States, 19096
Contact:Contact: Albert S. DeNittis 484-476-2649 ewend@mlhs.org
Contact:Principal Investigator: Albert S. DeNittis
United States, South Carolina
Medical University of South Carolina
[Recruiting]
Charleston, South Carolina, United States, 29425
Contact:Contact: Antonio Giordano 843-792-9321
Contact:Principal Investigator: Antonio Giordano
Greenville Health System Cancer Institute-Laurens
[Recruiting]
Clinton, South Carolina, United States, 29325
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Greenville Health System Cancer Institute-Easley
[Recruiting]
Easley, South Carolina, United States, 29640
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Gibbs Cancer Center-Gaffney
[Recruiting]
Gaffney, South Carolina, United States, 29341
Contact:Contact: Steven W. Corso 800-486-5941
Contact:Principal Investigator: Steven W. Corso
Saint Francis Hospital
[Recruiting]
Greenville, South Carolina, United States, 29601
Contact:Contact: Robert D. Siegel 864-255-1713
Contact:Principal Investigator: Robert D. Siegel
Greenville Health System Cancer Institute-Butternut
[Recruiting]
Greenville, South Carolina, United States, 29605
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Greenville Health System Cancer Institute-Faris
[Recruiting]
Greenville, South Carolina, United States, 29605
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Saint Francis Cancer Center
[Recruiting]
Greenville, South Carolina, United States, 29607
Contact:Contact: Robert D. Siegel 864-255-1713
Contact:Principal Investigator: Robert D. Siegel
Greenville Health System Cancer Institute-Eastside
[Recruiting]
Greenville, South Carolina, United States, 29615
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Greenville Health System Cancer Institute-Greer
[Recruiting]
Greer, South Carolina, United States, 29650
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Gibbs Cancer Center-Pelham
[Recruiting]
Greer, South Carolina, United States, 29651
Contact:Contact: Steven W. Corso 800-486-5941
Contact:Principal Investigator: Steven W. Corso
South Carolina Cancer Specialists PC
[Recruiting]
Hilton Head Island, South Carolina, United States, 29926-3827
Contact:Contact: Howard A. Zaren 912-819-5704
Contact:Principal Investigator: Howard A. Zaren
Greenville Health System Cancer Institute-Seneca
[Recruiting]
Seneca, South Carolina, United States, 29672
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
Spartanburg Medical Center
[Recruiting]
Spartanburg, South Carolina, United States, 29303
Contact:Contact: Steven W. Corso 800-486-5941
Contact:Principal Investigator: Steven W. Corso
Greenville Health System Cancer Institute-Spartanburg
[Recruiting]
Spartanburg, South Carolina, United States, 29307
Contact:Contact: Jeffrey K. Giguere 864-679-3966
Contact:Principal Investigator: Jeffrey K. Giguere
MGC Hematology Oncology-Union
[Recruiting]
Union, South Carolina, United States, 29379
Contact:Contact: Steven W. Corso 800-486-5941
Contact:Principal Investigator: Steven W. Corso
United States, South Dakota
Sanford Cancer Center-Oncology Clinic
[Recruiting]
Sioux Falls, South Dakota, United States, 57104
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
Sanford USD Medical Center - Sioux Falls
[Recruiting]
Sioux Falls, South Dakota, United States, 57117-5134
Contact:Contact: Preston D. Steen 712-252-0088
Contact:Principal Investigator: Preston D. Steen
United States, Tennessee
Vanderbilt-Ingram Cancer Center Cool Springs
[Recruiting]
Franklin, Tennessee, United States, 37067
Contact:Contact: Brent N. Rexer 800-811-8480
Contact:Principal Investigator: Brent N. Rexer
Thompson Cancer Survival Center
[Recruiting]
Knoxville, Tennessee, United States, 37916
Contact:Contact: Jashmin K. Patel 865-331-1812
Contact:Principal Investigator: Jashmin K. Patel
Thompson Cancer Survival Center - West
[Recruiting]
Knoxville, Tennessee, United States, 37932
Contact:Contact: Jashmin K. Patel 865-331-1812
Contact:Principal Investigator: Jashmin K. Patel
Thompson Oncology Group-Lenoir City
[Recruiting]
Lenoir City, Tennessee, United States, 37772
Contact:Contact: Jashmin K. Patel 865-331-1812
Contact:Principal Investigator: Jashmin K. Patel
Vanderbilt Breast Center at One Hundred Oaks
[Recruiting]
Nashville, Tennessee, United States, 37204
Contact:Contact: Brent N. Rexer 800-811-8480
Contact:Principal Investigator: Brent N. Rexer
Vanderbilt University/Ingram Cancer Center
[Recruiting]
Nashville, Tennessee, United States, 37232
Contact:Contact: Brent N. Rexer 800-811-8480
Contact:Principal Investigator: Brent N. Rexer
Thompson Oncology Group-Oak Ridge
[Recruiting]
Oak Ridge, Tennessee, United States, 37830
Contact:Contact: Jashmin K. Patel 865-331-1812
Contact:Principal Investigator: Jashmin K. Patel
United States, Texas
The Don and Sybil Harrington Cancer Center
[Recruiting]
Amarillo, Texas, United States, 79106
Contact:Contact: Brian T. Pruitt 806-212-1985 gcravey@harringtoncc.org
Contact:Principal Investigator: Brian T. Pruitt
Lyndon Baines Johnson General Hospital
[Recruiting]
Houston, Texas, United States, 77026-1967
Contact:Contact: Jennifer K. Litton 713-792-3245
Contact:Principal Investigator: Jennifer K. Litton
M D Anderson Cancer Center
[Recruiting]
Houston, Texas, United States, 77030
Contact:Contact: Jennifer K. Litton 713-792-3245
Contact:Principal Investigator: Jennifer K. Litton
MD Anderson Regional Care Center-Katy
[Recruiting]
Houston, Texas, United States, 77094
Contact:Contact: Jennifer K. Litton 713-792-3245
Contact:Principal Investigator: Jennifer K. Litton
MD Anderson Regional Care Center-Bay Area
[Recruiting]
Nassau Bay, Texas, United States, 77058
Contact:Contact: Jennifer K. Litton 713-792-3245
Contact:Principal Investigator: Jennifer K. Litton
MD Anderson Regional Care Center-Sugar Land
[Recruiting]
Sugar Land, Texas, United States, 77478
Contact:Contact: Jennifer K. Litton 713-792-3245
Contact:Principal Investigator: Jennifer K. Litton
MD Anderson Regional Care Center-The Woodlands
[Recruiting]
The Woodlands, Texas, United States, 77384
Contact:Contact: Jennifer K. Litton 713-792-3245
Contact:Principal Investigator: Jennifer K. Litton
United States, Vermont
Norris Cotton Cancer Center-North
[Recruiting]
Saint Johnsbury, Vermont, United States, 05819
Contact:Contact: Mary D. Chamberlin 603-354-5454 Ext. 2155 jmichelson@cheshire-med.com
Contact:Principal Investigator: Mary D. Chamberlin
United States, Virginia
IMG Hematology Oncology 8501
[Recruiting]
Fairfax, Virginia, United States, 22031
Contact:Contact: Mary J. Wilkinson 703-208-6650 Stephanie.VanBebber@inova.org
Contact:Principal Investigator: Mary J. Wilkinson
Bon Secours Memorial Regional Medical Center
[Recruiting]
Mechanicsville, Virginia, United States, 23116
Contact:Contact: William J. Irvin 877-668-0683 cancerclinicaltrials@med.unc.edu
Contact:Principal Investigator: William J. Irvin
Bon Secours Saint Francis Medical Center
[Recruiting]
Midlothian, Virginia, United States, 23114
Contact:Contact: William J. Irvin 877-668-0683 cancerclinicaltrials@med.unc.edu
Contact:Principal Investigator: William J. Irvin
Bon Secours Saint Mary's Hospital
[Recruiting]
Richmond, Virginia, United States, 23226
Contact:Contact: William J. Irvin 877-668-0683 cancerclinicaltrials@med.unc.edu
Contact:Principal Investigator: William J. Irvin
United States, Washington
Harrison HealthPartners Hematology and Oncology-Bremerton
[Recruiting]
Bremerton, Washington, United States, 98310
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Kadlec Clinic Hematology and Oncology
[Recruiting]
Kennewick, Washington, United States, 99336
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Seattle Cancer Care Alliance at EvergreenHealth
[Recruiting]
Kirkland, Washington, United States, 98034
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
PeaceHealth Saint John Medical Center
[Recruiting]
Longview, Washington, United States, 98632
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Skagit Valley Hospital Regional Cancer Care Center
[Recruiting]
Mount Vernon, Washington, United States, 98273
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
Skagit Valley Hospital
[Recruiting]
Mount Vernon, Washington, United States, 98274
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
Harrison HealthPartners Hematology and Oncology-Poulsbo
[Recruiting]
Poulsbo, Washington, United States, 98370
Contact:Contact: Mehmet S. Copur 501-622-2100
Contact:Principal Investigator: Mehmet S. Copur
Fred Hutchinson Cancer Research Center
[Recruiting]
Seattle, Washington, United States, 98109
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
Seattle Cancer Care Alliance
[Recruiting]
Seattle, Washington, United States, 98109
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
Swedish Medical Center-First Hill
[Recruiting]
Seattle, Washington, United States, 98122-4307
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
Seattle Cancer Care Alliance at Northwest Hospital
[Recruiting]
Seattle, Washington, United States, 98133
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
University of Washington Medical Center
[Recruiting]
Seattle, Washington, United States, 98195
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
Spokane Valley Cancer Center-Mayfair
[Recruiting]
Spokane, Washington, United States, 99208
Contact:Contact: Julie R. Gralow 800-422-6237
Contact:Principal Investigator: Julie R. Gralow
PeaceHealth Southwest Medical Center
[Recruiting]
Vancouver, Washington, United States, 98664
Contact:Contact: Gary E. Goodman 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org
Contact:Principal Investigator: Gary E. Goodman
United States, West Virginia
Edwards Comprehensive Cancer Center
[Recruiting]
Huntington, West Virginia, United States, 25701
Contact:Contact: Maria R. Tria Tirona 304-399-6617
Contact:Principal Investigator: Maria R. Tria Tirona
United States, Wisconsin
Gundersen Lutheran Medical Center
[Recruiting]
La Crosse, Wisconsin, United States, 54601
Contact:Contact: David E. Marinier 608-775-2385 cancerctr@gundersenhealth.org
Contact:Principal Investigator: David E. Marinier
ProHealth D N Greenwald Center
[Recruiting]
Mukwonago, Wisconsin, United States, 53149
Contact:Contact: Timothy R. Wassenaar 262-928-7632
Contact:Principal Investigator: Timothy R. Wassenaar
Cancer Center of Western Wisconsin
[Recruiting]
New Richmond, Wisconsin, United States, 54017
Contact:Contact: David M. King 952-993-1517 mmcorc@healthpartners.com
Contact:Principal Investigator: David M. King
ProHealth Oconomowoc Memorial Hospital
[Recruiting]
Oconomowoc, Wisconsin, United States, 53066
Contact:Contact: Timothy R. Wassenaar 262-928-7632
Contact:Principal Investigator: Timothy R. Wassenaar
ProHealth Waukesha Memorial Hospital
[Recruiting]
Waukesha, Wisconsin, United States, 53188
Contact:Contact: Timothy R. Wassenaar 262-928-7632
Contact:Principal Investigator: Timothy R. Wassenaar
UW Cancer Center at ProHealth Care
[Recruiting]
Waukesha, Wisconsin, United States, 53188
Contact:Contact: Timothy R. Wassenaar 262-928-7632
Contact:Principal Investigator: Timothy R. Wassenaar
Puerto Rico
Cancer Center-Metro Medical Center Bayamon
[Recruiting]
Bayamon, Puerto Rico, 00959-5060
Contact:Contact: Luis Baez-Diaz 800-449-8729
Contact:Principal Investigator: Luis Baez-Diaz
Doctors Cancer Center
[Recruiting]
Manati, Puerto Rico, 00674
Contact:Contact: Luis Baez-Diaz 800-449-8729
Contact:Principal Investigator: Luis Baez-Diaz
Hato Rey Hematology Oncology Group
[Recruiting]
San Juan, Puerto Rico, 00917
Contact:Contact: Luis Baez-Diaz 800-449-8729
Contact:Principal Investigator: Luis Baez-Diaz
San Juan City Hospital
[Recruiting]
San Juan, Puerto Rico, 00936
Contact:Contact: Luis Baez-Diaz 800-449-8729
Contact:Principal Investigator: Luis Baez-Diaz
Open or close this module IPDSharing
Plan to Share IPD:
Open or close this module References
Citations:
Links:
Available IPD/Information:
Scroll up to access the controls Scroll to the Study top
U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services